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Abstract
Jaclyn Ann Witko
EFFECTS OF BIOENGINEERING SCAFFOLDS RELEASING NEUROTROPHINS AND
BODY WEIGHT SUPPORTED TREADMILL TRAINING

2015 - 2016
Tom Merrill, Ph.D.
Master of Science in Mechanical Engineering

Changes in monosynaptic reflex, often used to study spasticity, has been tested
through the H-reflex in spinal cord injury (SCI) patients after rehabilitation training, such
as body weight support treadmill training or cycling. The combinational effects of
rehabilitation training and a bioengineered scaffold on spasticity in SCI animal model
have not been studied. We used a clinically relevant animal model of spinal cord
moderate contusion at T9/T10 with BWSTT and the bioengineered scaffold PNIPAAmg-PEG loaded with the growth factors BDNF/NT-3 to measure the efficiency of the
combinational bioengineered approach to treat spasticity. Five animal groups were
included in the study: sham, injury, SCI + BWSTT, SCI + PNIPAAm-g-PEG with
BDNF/NT-3 (Transplant), and SCI + BWSTT/PNIPAAm-g-PEG with BDNF/NT-3
(combinational). Results indicate that there was an increase in the over ground BBB test
scores from the BWSTT, and combinational groups from weeks 6-8, but not in the
transplant only or injury groups when compared to the sham. There was also a decrease
in habituation of the H-reflex and restoration of rate depression properties in both the
BWSTT and combinational groups.
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Chapter 1
Introduction
Background
Spinal cord injury (SCI) affects an estimated 40 cases per million population in the
United States with about 12,500 new cases reported each year, according to the National
Spinal Cord Injury Statistical Center. Studies have shown that vehicle crashes are the
leading cause of injury, and spinal cord injuries are the second leading cause of paralysis
among Americans (Christopher and Dana Reeve Foundation, April 2009). There is no
known cure for spinal cord injuries and available treatments just help minimize pain and
discomfort, thereby slowing the progression of secondary damage. One such secondary
problem that results after SCI is spasticity, which is reported in 65 -78% of patients
(Adams et al., 2005). Treatment options are currently available to decrease spasticity and
the associated pain and discomfort. One of those treatments is an activity based
rehabilitation therapy, which includes body weight support treadmill training. Body
weight support treadmill training after an incomplete spinal cord injury can help retrain
the complex circuitry and connections within the spinal cord (SC), resulting in functional
improvement. Since greater sparing within the SC after injury can result in higher
functional improvement (Nógrádi et al., 2000-), neuroprotection and regeneration
transplantation treatment strategies, combined with training, should improve the
outcomes after body weight support treadmill training. Transplantation of cells that have
been genetically engineered to deliver neurotrophins, such as brain derived nerve growth
factor, (BDNF) or neurotrophin-3 (NT-3), because they have neuroprotective and
neuroregenerative properties. BDNF has been studied and shown to stimulate growth of
1

vestibulospinal fibers (Boyce et al., 2014), which are fibers found within the
vertibulospinal tract that runs along each side of the central nervous system (Pease,
2006). BDNF has also been found to cause increased excitability of motor neuron in an
injured spinal cord, but has no effect on the strength of synaptic projections to motor
neurons, unlike NT-3. NT-3 will enhance the strength of synaptic projection to the motor
neurons and will increase corticospinal fiber growth (Boyce et al., 2014). These fibers are
found in the corticospinal tract, which consists of four columns of motor fibers that run
along either side of the spinal cord (Pease, 2006). The BDNF and NT-3 will work
together after injury to protect and minimize the secondary damage of the pathways,
while promoting growth of new pathways based on their properties of repairing the spinal
cord (Boyce et al., 2014). These neurotrophins have the potential to help reduce spasticity
because it is caused by the damage that occurs to the nerve pathways (Reese et al., 2006).
Previous studies conducted by Skinner et al., 1996 and Phadke et al., 2006, among others
have shown that if there are more spared pathways within the injury site that are
preserved, the less severe spasticity the patient will experience.
Many different cell types pose a problem when tested in animal models in regards to
rejection, regulation of release among others (Assuncáo-Silva et al., 2014). To overcome
these problems, our study uses the bioengineered scaffold poly N-(isopropylacrylamide)
– poly (ethylene glycol) (PNIPAAm-PEG) loaded with neurotrophins as a transplant
because it has shown to be highly biocompatible, and when functionalized to secrete a
neutrtrophic factor, it can promote regeneration and functional recovery in a surgically
induced spinal cord injury animal model (Comolli et al., 2009).
2

Problem statement. To study changes in monosynaptic, also known as H-Reflex,
reflex pathway after combinational treatment using bioengineered scaffold (PNIPAAMPEG) secreting neurotrophins (BDNF+NT3) and rehabilitation training using body
weight support treadmill training (BWSTT) in a clinically relevant contusion spinal cord
injury (SPI) animal model.
Hypothesis. Neurotrophins secreting scaffold will protect and minimize the
secondary damage that the descending pathways undergo, while promoting growth of
new pathways that together will help restore the H-reflex response after body weight
support treadmill training (BWSTT).
Organization of thesis. This first chapter is an outline of why our research is relevant
to spinal cord injuries. It states the problem statement along with the hypothesis
proposed. Chapter 2 discusses the spinal cord in detail, including injury types, anatomy,
and current treatments for spinal cord injuries. Chapter 3 discusses the reflexes and
spasticity that occur in the spinal cord, how they are studied, and how they relate to the
current problem statement and hypothesis. Chapter 4 presents therapeutic approaches to
treat spasticity in spinal cord injuries, including rehabilitation, transplant, and
combinational biomaterials. Chapter 5 is the manuscript, and provides a draft for future
publication. Lastly, Chapter 6 is conclusions and future work, and discusses where the
research will lead in the future and more studies that are needed in order to enhance
spinal cord injury research.
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Chapter 2
The Spinal Cord
Anatomy
Vertebral column (spine). The vertebral column, commonly known as the spine,
consists of vertebrae and intervertebral (IV) discs. The vertebrae of the spine are broken
down into five different sections: cervical, thoracic, lumbar, sacrum, and coccyx. They
can be seen in Figure 1 from both the anterior and right lateral views. The five sections of
the spine will be discussed in more detail in the upcoming sections (2.1.1.1). The spine
runs from the base of the skull to the bottom of the coccyx, and typically measures 72 -75
cm long (Figure 1D). The intervertebral discs account for approximately one quarter of
the spine. There are five different joints of the vertebral column (Moore, 1980). The
vertebral column is capable of producing six different motions: flexion, extension, lateral
flexion and extension, and rotation. These movements can be seen in Figure 2.
There are a total of four curvatures of the adult spine: thoracic, sacral kyphosis,
cervical, and lumbar lordosis. Figure 3 illustrates the development of the curvatures in the
spine throughout infancy, childhood and adulthood. Figure 4 shows the surface anatomy
of the four curvatures. The thoracic and sacral kyphosis are concaved anteriorly and are
considered primary curvatures that develop during the fetal period. The other two
curvatures, cervical and lumbar lordosis, are secondary curvatures that are concave
posteriorly. These secondary curvatures result from the extension from the flexed fetal
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position. The curvatures of the vertebral column also provide additional flexibility
(shock-absorbing resilience) in combination with the intervertebral discs (Moore, 1980).

(Moore, 1980)
Figure 1. Vertebral column and its five regions (Moore, 1980).
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(Moore, 1980)
Figure 2. Movements of vertebral column (Moore, 1980).

(Moore, 1980)
Figure 3. Curvatures of vertebral column (Moore, 1980).
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(Moore, 1980)
Figure 4. Surface anatomy of curvatures of vertebral column (Moore, 1980).

Vertebrae. Vertebrae are one of the components that make up the vertebral
column. There are a total of 33 vertebrae in five different regions. The cervical region has
7, 12 of which are in thoracic, 5 in lumbar, 5 in sacral and 4 in coccygeal. The vertebrae
in the cervical, thoracic and lumbar regions are considered superior vertebrae. These
regions are where the most amount of movement is seen, and the sacral and coccygeal
regions are considered inferior vertebrae. The vertebrae in the sacral and coccygeal
regions will eventually fuse together, about age 30, to form the sacrum and coccyx. As
shown in Figure 1A, there is an increase in size of the vertebrae as one moves down the
vertebral column to the sacrum where they become smaller. Figure 5 illustrates a typical
structure of the vertebrae, including of a vertebral body, a vertebral arch and seven
processes (Moore, 1980).
7

(Moore, 1980)
Figure 5. Typical vertebra, represented by the 2nd lumbar vertebra (Moore, 1980).

Intervertebral (IV) discs. IV discs can be found in between the vertebral bodies
(Figure 6). The discs made up between 20 -25% of the entire vertebral column. The main
roles of intervertebral discs are to allow movement between adjacent vertebrae and
provide an extra layer of “cushion” to absorb the shock. The IV disc has two parts: the
anulus fibrosus and nucleus pulposus. The nucleus pulposus is the inner gelatinous
central mass and is surrounded by the annulus fibrosus. The anulus fibrosus is a ring
made up of concentric layers of fibrocartilage, which protects the nucleus pulposus,
located at the core of the disc. The nucleus pulposus is a very important part of the
vertebrae because it is responsible for the flexibility and resilience of the IV disc and the
vertebral column, due to its semifluid nature. The core of the disc is constantly deforming
8

due to vertical forces. When the vertebral column is compressed it becomes broader, and
when it is stretched it is thinner. The structure and function of the IV discs can be seen in
Figure 7 (Moore, 1980).

(Moore, 1980)
Figure 6. Lateral view of the lumbar vertebrae (Moore, 1980).
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(Moore, 1980)
Figure 7. Structure and function of intervertebral (IV) discs (Moore, 1980).

Nervous system. The nervous system can be broken down into two separate parts
the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS
consists of the brain and the spinal cord, and the PNS contains nerve fibers and cell
bodies outside the central nervous system. Figure 9 shows the basic organization of the
nervous system. Both the CNS and PNS will be discussed in more detail in the next two
sections (Moore, 1980).
Nervous tissue contains two main cell types - neurons and neuroglia. Neurons are
known for their rapid communication and are classified into two main groups - multipolar
motor neurons and pseudounipolar sensory neuron. Neurons are all comprised of a cell
body and an axon. The cell body has extensions named dendrites, which carry impulses
to the cell body, and the axon carries the impulse away from the cell body. Some axons
of the neurons will be encapsulated by a myelin sheath, which consists of layers of lipids
10

and proteins. This myelin sheath increases the velocity of the impulse conduction. These
neurons will communicate with each other through synapses. Synapses are simply just
the points of contact between neurons. Figure 8 show a pictorial representation of a
multipolar motor neurons synapsing. During a synapse, communication occurs through
neurotransmitters that have been secreted by a neuron. The communication is received by
another neuron. This process keeps continuing until communication is finished and a new
synapse occurs. Neuroglia, which are more commonly known as glial cells, function to
support the neurons. They are five times more abundant than neurons are. There are
different neuroglia within the CNS and PNS. In the CNS, they include oligodendroglia,
astrocytes, ependymal cells, and microglia. In the PNS they can include satellite cells and
Schwann cells (Moore, 1980).

11

Figure 8. Multiple motor neurons synapsing (Moore, 1980).
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(Moore, 1980)
Figure 9. Basic organization of the spinal cord (Moore, 1980).

Central nervous system (CNS). The CNS consists of the brain and spinal cord,
and allows incoming and outgoing neural signals to coordinate to produce movements, as
well as to carry out higher mental functions. The brain and the spinal cord are composed
of gray and white matter. The gray matter, at the center of the spinal cord, resembles the
shape of the letter H, and is composed of nerve cell bodies (Moore, 1980). The
arrangement of the gray matter is organized into nine distinct laminae, labeled I through
IX (Figure 10); (Nógrádi et al., 2000-). The white matter surrounds the gray matter and is
an interconnecting fiber tract system. The CNS is protected by meninges and the
13

cerebrospinal fluid (CSF). The meninges are a three-layered membrane that is made up of
the pia mater, arachnoid mater and dura mater. The pia mater is the inner most layer and
is directly covers the spinal cord. The arachnoid mater is the middle layer, and the
outermost layer is the dura mater. The dura mater is very tough, unlike the pia mater
which is very delicate. The cerebrospinal fluid is found between the pia mater and the
arachnoid mater. The meninges are shown in Figure 11 (Moore, 1980).

(Anatomy)
Figure 10. Spinal cord nuclei and laminae (Anatomy).
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(Moore, 1980)
Figure 11. Spinal cord and spinal meninges (Moore, 1980).

Peripheral nervous system (PNS). The PNS consists of the nerve fibers and cell
bodies that lie outside the brain and spinal cord. In Figure 9, the different part of the PNS
is marked by two red asterisks. This system can either conduct impulses to or away from
the brain and spinal cord. PNS is an organization of nerves (Moore, 1980).
A nerve is composed of nerve fibers which have three parts - an axon, its
neurolemma, and endoneurial connective tissue. A neurolemma is another term for
Schwann cell. The Schwann cells have two forms they can take, which then gives rise to
two different nerve fibers, myelinated and unmyelinated. The difference between the two
nerve fibers is their ability to produce myelin. As stated previously, myelin increases the
speed at which the impulses are conducted. Myelinated nerve fibers have Schwann cells
that are specific to a particular axon and an unmyelinated nerve fiber has Schwann cells
15

that are not specific to just one axon. An illustration of myelinated and unmyelinated
nerve fibers is shown in Figure 13. Nerves are simply a bundle of nerve fibers that are
surrounded by a connective tissue covering loaded with blood vessels that nourish the
entire nerve. The connective tissue covering is divided into three parts - endoneurium,
perineurium and epineurium. These three parts together allow the nerve to be fairly
strong and resilient. Figure 13 shows the endoneurium as the innermost layer surrounding
the nerve fiber and the epineurium being the outermost layer (Moore, 1980).
The nerves of the peripheral nervous system are broken down into two main
sections - cranial nerves and spinal nerves. Spinal nerves exit the vertebral column and
are known as rootlets, which then form two nerve roots. The two nerve roots are anterior
(ventral) and posterior (dorsal). The anterior (ventral) nerve root has motor (efferent)
fibers that convey neural impulses from the brain and spinal cord to effector organs,
which include muscles and glands. The posterior (dorsal) nerve root has sensory
(afferent) fibers that convey neural impulses to the brain and spinal cord from sensory
organs and sensory receptors. Figure 14 shows how the nerve roots form from the rootlets
and stem from either side of the grey matter (Moore, 1980).

16

(Moore, 1980).
Figure 12. Myelinated and unmyelinated nerve fibers (Moore, 1980).

(Moore, 1980)
Figure 13. Arrangement and ensheathment of myelinated nerve fibers (Moore, 1980).
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(Moore, 1980)
Figure 14. Spinal cord gray matter, spinal roots, and spinal nerves (Moore, 1980).

Spinal Cord Injury
Epidemiology. SCI is reported in 25.5 cases per million or about 40 million
people worldwide. The average age of these people is 31.7 years, mainly ranging from 20
to 35 (Assuncão-Silva et al., 2014; Nas et al., 2015). Spinal cord injuries are more
commonly seen in young men (Assuncão-Silva et al., 2014), but 1% of the reported cases
are children (Nas et al., 2015). In children 60-80% of injuries occur in the cervical region,
and the remaining 20-45% are split evenly between the thoracic and lumbar regions (Nas
et al., 2015). The number one cause of spinal cord injuries is due to motor vehicle
accidents (24%), followed by accident working (28%) and sporting/recreation (16%)
(Christopher and Dana Reeve Foundation, April 2009). Another major number for spinal
cord injuries are that they are the second leading cause of paralysis (23%) after stroke
(29%). The exact breakdown of the numbers per cause of spinal cord injuries and cause
18

of paralysis can be seen in the two pie charts below (Figures 15 and 16) (Christopher and
Dana Reeve Foundation, April 2009).
Spasticity is reported in over a half a million people in the United States and over
12 million people all over the world (Voerman et al., 2005). Literature also report that it
affects 42.7%, 65-78%, 70% and 80% of people living with spinal cord injuries
(Kakebeeke et al., 2005; Adams et al., 2005; Hagen, 2015; Elbasiouny et al., 2015;
respectively). Even after 10 years post injury, 35% of patients still reported having
spasticity as a side effect (Kakebeeke et al., 2005).

(Christopher and Dana Reeve Foundation, April 2009)
Figure 15. Causes of Spinal Cord Injuries.
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(Christopher and Dana Reeve Foundation, April 2009)
Figure 16. Causes of Paralysis.

Injury types. Spinal cord injuries are classified into two main types, complete
and incomplete. A complete injury is considered to be traumatic and an incomplete injury
is non-traumatic (Sabapathy et al., 2015). When a person has a complete spinal cord
injury they have a complete loss of motor and sensory functions from the point of injury
down to the distal point of the spinal cord. On the other hand, an incomplete spinal cord
injury has partial motor and sensory functions below the level of neurological disrupt and
in the lower sacral segments (Kirshblum et al., 2011; Nas et al., 2015). Typically, spinal
cord injuries are caused by flexion, compression, hyperextension or flexion-rotation
mechanisms. This initial response of these mechanisms is known as the primary damage.
The secondary damage is the response from the body because of the primary damage.
Secondary damage is seen in the form of hemorrhaging, inflammation and the release of
different chemicals from the body (Nas et al., 2015).
20

American spinal injury association (ASIA). Spinal cord injury patients are
classified using the Spinal Injury Association (ASIA) scale (Kirshblum et al., 2011; Nas
et al., 2015). This scale was last revised in 2011 (Nas et al., 2015). The scale ranges from
A-E, where A is the most severe injury and E is completely normal. The table below
outlines each level of the scale and what classifies a patient in the different levels
(Kirshblum et al., 2011; Nas et al., 2015).

(Nas et al., 2015)
Figure 17. American Spinal Injury Association scale for spinal cord injury

Animal Models of Spinal Cord Injuries
Different animal models are used depending on the research that is being
performed. There are four main types of models that are used for spinal cord injury
research, which include hemi-section, compression, contusion, and transection. Table 1
below shows a summary of the current spinal cord injury animal models that are used to
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mimic human spinal cord injuries. To simulate an incomplete spinal cord injury, the
hemi-section, compression and contusion models are typically used, and for a complete
injury a transection model is used. For our study, we performed a moderate contusion
injury at T9/T10 using a weight drop system. In a hemi-section model, a portion of the
spinal cord is removed at the desired level, simulating an incomplete injury where the
transection model removes the entire cross-section of the spinal cord at a particular level.
In the compression and contusion models, a dorsal laminectomy is performed first to
expose the spinal cord. In the compression models, calibrated forceps are used to
compress the exposed spinal cord, and in the contusion model a weight drop device is
dropped on the particular level of injury desired. The weight drop system can account for
a mild, moderate, or severe injury depending on the height it is dropped from. Figure 18
shows a contusion and compression injury being performed (Blight, 2000).
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Table 1
Summary of the current SCI animal models that are used in research to mimic the
clinical human SCI.

(Kundi et al., 2013)
Note: These animal models are used to asses, behavior, histology and genetic alterations
following SCI, but more importantly to assess neural and molecular outcomes. These
models are more frequently developed on Rat and Mice and less frequently on larger
animals such as Cats and Dogs (Kundi et al., 2013).
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(Blight, 2000)
Figure 18. Contusion and compression injuries of the spinal cord usually involve
exposing the spinal cord with a dorsal laminectomy, typically in the thoracic region but
sometimes in cervical or lumbar spinal cord. The spinal cord is then compressed, either
from the dorsal surface (A, B) or from the sides (C,D). In contusion injury, a cylindrical
weight (A) is dropped from a given height into the spinal cord or a similar cylinder may
be depressed with a motor, controlled by a computer. In static compression injuries a
heavier weight is simply placed onto the spinal cord. In both cases, the dorsal surface of
the spinal cord is displaced downward. This produces distributed hemorrhage in the
spinal cord at the site of compression. The compression also produces a displacement of
the central contents of the cord in cranial and caudal directions (B), particularly in a
narrow region above and around the central canal. Lateral compression injury can be
produced with calibrated forceps that are inserted on either side of the spinal cord (C) and
closes together(D) inducing a similar central hemorrhagic necrosis and displacement of
the centrally located, damage tissue in cranial and caudal directions (Blight, 2000).
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Pathophysiology of SCI
In an event of a trauma to the spinal cord, there is primary and secondary damage.
When the initial injury occurs, the body triggers a series of cellular and biochemical
events that allow a lesion or injury site to form in the spinal cord. Some of the immediate
changes that occurs after this primary damage are disrupted blood vessels and extensive
apoptosis (Assuncão-Silva et al., 2014). After the primary damage is done secondary
damage starts to set in. The secondary damage changes depending on the severity of the
primary damage, and can be divided into three different sections - acute phase, subacute
phase, and chronic phase. Each of these phases has a timeline associated with themacute: 2 hours to 2 days, subacute: days to weeks, and chronic: months to years
(Sabaphathy et al., 2015). Initially, in the secondary damage in the acute phase, an
inflammatory environment occurs because of cellular and molecular interaction of
macrophages, neutrophils and leukocytes (Assuncão-Silva et al., 2014; Sabaphathy et al.,
2015). The purpose of these interactions is to phagocyte cell debris and to prevent further
tissue damage. Then, in the subacute phase, a fluid-filled cyst forms at the injury site,
where a glial scar forms around the cyst. The glial scar is mainly made up of reactive
astrocytes and is supposed to stabilize and protect the damaged spinal cord. In reality, the
glial scar and its cells release inhibitory proteins such as chondroitin sulfate
proteoglycans (GSPGs) and axonal growth inhibitors. These proteins and inhibitors do
not allow axonal regeneration and remyelination along the damaged spinal cord
(Assuncão-Silva et al., 2014). Figure 19 below is a pictorial representation of the
mechanism of a spinal cord injury. At the injury or lesion site, the neural tracks have been
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severed, the formation of the glial scar appeared and lymphocytes, monocytes and
activated astrocytes appeared to help minimize injury. These three cells tend to appear
within the subacute phase (Sabapathy et al., 2015).

(Sabapathy et al., 2015)
Figure 19. Mechanism of spinal cord injury (Sabapathy et al., 2015).

Spasticity after SCI. The cause of spasticity is still unknown, but from the
previous epidemiology section we know it greatly affects spinal cord injury patients.
Spasticity is one of the symptoms of the upper motor neuron syndrome and is seen in the
form of exaggeration of the stretch reflex, secondary to hyper-excitability of spinal
reflexes (Adams et al., 2005; Elbasiouny et al., 2010). It can also be seen in forms other
than reflexes, such as hyperreflexia, clonus, clasp-knife responses, ling-lasting cutaneous
reflexes, and muscle spasms. Spasticity develops gradually, starting in the subacute
phase. After injury, the spinal cord is in spinal shock, which is seen by the loss of tendon
reflexes below the injury site. Muscle paralysis and flaccid muscle tone occurs. Over the
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span of the subacute and chronic phases, new reflexes start to appear, like the tendon
reflex among others. This causes the threshold of the flexor reflexes to decrease over
time, which can cause long-lasting contractions. Later the extensor reflexes start to occur,
which makes the flexor/extensor muscles co-contract and become more prominent. Other
stimulus, such as heat/cold and bladder distention can also cause these muscle spasms
that we know as spasticity. There are many factors that affect spasticity and its severity
(Elbasiouny et al., 2010).
Current Treatments
There are three different categories of current treatments for spinal cord injuries.
The three categories are pharmaceutical, transplant, and rehabilitation. Pharmaceutical
treatment only includes one drug, methylprednisolone more commonly known as Medrol.
Transplant and rehabilitation treatments are part of the therapeutic approaches to treat
spinal cord injuries. Transplant treatments include cell-based therapies, hydrogel-based
biomaterials and combinational biomaterials. Rehabilitation strategies include body
weight support treadmill training, functional electrical stimulation and cycling. Next three
sections, will elaborate more on the different categories of current treatments. In Chapter
4, the therapeutic approaches will be discussed in further detail.
Pharmaceutical. The only pharmaceutical that is used for treatment in spinal
cord injuries is methylprednisolone (Medrol). There were three large randomize clinical
trials - the National Acute Spinal Cord Injury Studies (NASCIS) I, II, III - that made this
drug the standard for spinal cord injuries. In the first NASCIS trial, patients were
examined for changes in their motor function and sensation. This trial produced results
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that showed no benefit, which was thought to be due to the dosage being below the
therapeutic threshold. The second phase of the NASICS trial used a higher dose of
Medrol administered through a 24-hour infusion within 12 hours after injury
(Hugenholtz, 2003). Results from this trial showed no benefit except during post hoc
analysis. Post hoc analysis showed that within 8 hours of injury there was a small gain in
the motor and sensory score. The NASCIS II allowed Medrol to become the standard
care for acute spinal cord injuries. NASCIS III further refined the protocol that was used
to administer Medrol (Framptom et al., 2006; Hugenholtz, 2003). Even though Medrol
became the standard, many other clinical trials have provided conflicting evidence. Even
though it is used today, it is still a controversial drug and its ability to help spinal cord
injury patients is still uncertain (Hugenholtz, 2003; Hugenholtz et al., 2002).
Transplant. Transplantation therapies in animal models of SCI are currently
being investigated extensively for their translation capabilities. Some of the therapies
being researched for transplantation are cell-bases therapies, which include stem cells,
hydrogel-based biomaterials, which include both natural and synthetic hydrogels, and the
combination of both cell-based therapies and hydrogels. When looking at cell-based
treatments they must be able to possess the ability to 1) minimize the secondary injury, 2)
replace and minimize the survival of damaged cells and 3) alter the local environment to
be more conductive for regeneration (Sabapathy et al., 2015; Tam et al., 2014). In
general, stem cells have been tested from different origins to see if they are capable of
nerve regeneration and possess the ability to restore the complex circuitry of the spinal
cord when transplanted into the injury site. More on the specific outcomes from the
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different types of stem cells can be found in Chapter 4. Hydrogel-based biomaterials have
become popular in spinal cord repair because hydrogels have great physical properties
and chemical composition. The physical properties allow the hydrogel to have the ability
to mimic the environment of the central nervous system and its chemical composition is
easily integrated into the extracellular matrix. Hydrogels, because they are a biomaterial,
still have to overcome biocompatibility, mechanical and physicochemical properties,
porosity and permeability, and biodegradability. The hydrogel-based biomaterials are
extensively outlined in Chapter 4 under the hydrogel-based biomaterials section
(Assuncão-Silva et al., 2014).
Rehabilitation. Rehabilitation is currently the most widely used treatment for
spinal cord injuries. This therapeutic rehabilitation includes body weight support
treadmill training, functional electrical stimulation, and cycling. These approaches have
shown to have the capability to decrease symptoms of spinal cord injury, especially
spasticity. More on these three rehabilitation strategies can be found in Chapter 4.
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Chapter 3
Reflexes and Spasticity
Overview
The Hoffmann (H) - reflex is a monosynaptic reflex (Lee et al., 2005; Gozariu et
al., 1998) elicited by the synaptic activation of motor neurons by muscle afferents
following stimulation of muscle nerves (Reese et al., 2006; Skinner et al., 1996) that was
first studied in the 20th century by Paul Hoffman on the triceps surae. In 1973, Hoffman
published “Methodology of the Hoffman Reflex in Man” which became the guidelines of
parameters for achieving the H-reflex (Tucker et al., 2005; Gozariu et al., 1998).
In a non-injured patient, the expected outcome of the H-reflex is decrease in the
amplitude with increasing stimulus frequency of 1Hz or higher (Reese et al., 2006) while
the M-wave amplitude remains constant (Figure 20). The M- and H-wave are obtained
through an electrical stimulation of a peripheral nerve that innervates the muscle where
the H-reflex is recorded. When a single stimulus is initiated, it generates a short latency
M-wave and long latency H-wave. The M-wave appears because of the direct stimulation
of the motor axons innervating the muscle, and the H-wave is the measure of the alpha
motor neurons activated by Ia afferents (Lee et al., 2005). After injury, the H-wave
amplitude become less sensitive to stimulation, which results in a higher H/M ratio, and
the ratio becomes higher at the baseline stimulus frequency (Lee et al., 2005). The Mand H-wave will be discussed in more detail in the Section 3.3.
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Spasticity is a common side effect of spinal cord injuries and can be seen when
testing the H-reflex. Spasticity is measured through the habituation that occurs during
electrical stimulation. When there is no habituation that occurs at higher frequencies it is
known that spasticity occurred because of the spinal cord injury. This habituation can be
seen by observing the M- and H-wave during testing (Yates et al., 2008). Spasticity can
cause loss of mobility and produce pain from muscle spasms (Mukherjee et al., 2010).
From Chapter 2 we know that spasticity occurs after injury to the spinal cord and is also
the most observed phenomena after injury. There is no one exact cause of spasticity, it
occurs from a combination of effects. Spasticity effects over a half a million spinal cord
injury patients in the United States and over 12 million worldwide (Voerman et al.,
2005). More on spasticity and how it relates to the H-reflex and the effects of different
rehabilitation strategies will be discussed later in this chapter in Section 3.4.

(Lee et al., 2005)
Figure 20. Response of H-reflex for a non-injured animal with increasing stimulus
frequency. The H-wave decrease with increasing frequency while the M-wave remains
constant (Lee et al., 2005).
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Spasticity
Spasticity is known to be one of the secondary symptoms that occur after spinal
cord injuries and occurs in 65-78% (Adams et al., 2005) of patients who have had a
chronic spinal cord injury for more than a year. It has been reported that in complete
spinal cord injuries spasticity starts to appear 2-6 months after injury (Hagen, 2015).
Spasticity has many definitions, but the most commonly agreed upon within the scientific
community is that it is “a velocity-dependent increase in the tonic stretch reflexes
(muscle tone) with exaggerated tendon jerks, resulting from the hyper-excitability of the
stretch reflex as one component of the upper motor neuron (UMN) syndrome” (Adams et
al., 2005; Mukherjee et al., 2010; Voerman et al., 2005). The upper motor neuron
syndrome is the motor changes that occur in the descending motor pathways after injury
to the spinal cord (Purves et al., 2001). In simpler terms, spasticity can affect both
muscles and joints by having an abnormal increase in muscle tone or stiffness of the
muscles. This can cause pain and discomfort, can interfere with movement or speech, and
cause deformities and abnormal movements (NINDS; Voerman et al., 2005). Spasticity is
typically caused by the damage that occurs to the nerve pathways. Some of the symptoms
that occur with spasticity include hypertonicity (increased muscle tone), hyper-reflexia
(Reese et al., 2006), clonus (a series of rapid muscle contractions), exaggerated deep
tendon reflexes, muscle spasms, scissoring (involuntary crossing of the legs) and fixed
joints (contractures). Spasticity does not just occur in spinal cord injuries, but also in
patients with multiple sclerosis, cerebral palsy and others (NINDS). Today there is no
current treatment that is used to cure spasticity, only treatments to reduce the symptoms.
These treatments include medications, physical therapy and surgery. One important thing
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to keep in mind is that no one treatment will be effective for all spinal cord injuries. The
key is to manage each case based on the unique goal of the patient (Adams et al., 2005;
NINDS). The next two sections will discuss spasticity and the reflexes of both humans
and animals in different spinal cord injury models. Chapter 4 Section 4.1, will discuss
spasticity after a therapeutic approach has been used, and its outcomes.
Reflexes
M-wave. One of the responses of stimulating a mixed nerve within the triceps
surae is the M-wave. An electrical current is passed through a mixed nerve, including
both muscle spindle afferents and motor efferents of the test muscle, initiating the
response. The concept of mixed nerve is shown in Figure 21. When comparing the Mwave and the H-wave, the M-wave will appear at a higher stimulation than the H-wave
because of the relatively thinner size of the motor nerves, compared with the muscle
spindle Ia afferents. It also occurs at shorter latency (< 4 ms, Skinner et al., 1996; Gozariu
et al., 1998; 5-8 ms, Tucker et al., 2005) with a maximal amplitude occurring in the range
of 6-8 mV (Gozariu et al., 1998), because it has to travel only along the motor axons,
approximately 5-8 milliseconds in the soleus muscle (Tucker et al., 2005).
The M-wave is used in studies to normalize the H-reflex results obtained. When
normalizing the results, the H-reflex is a ratio of the maximum M-wave (M-max, H/Mmax). When the M-wave was initially studied it was believed that it was a successful and
accurate way of measuring the total muscle activation. Further investigation showed that
the maximum M-wave changes during experiments due to the different limb positions
and/or during different levels of muscle contractions. This variability seen in the
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maximum M-wave is due to the changes in the angle of the muscle fibers and electric
stimulation. Other factors affecting the maximum M-wave are the experimental time, the
decrease of the maximum M-wave value over time, time of day the experiment is
conducted, and temperature of the muscle being tested. Many factors can change the
value of the maximum M-wave, so when it is used as a normalization factor it should be
recorded in all condition to obtain the most accurate results (Tucker et al., 2005).
H-wave. The second response of electromyography testing is the H-reflex, which
is a long latency (> 4 ms, Skinner et al., 1996; 11-12 ms, Gozariu et al., 1998; 3-4 ms,
Tucker et al., 2005) compound electromyographic response with a maximal amplitude
ranging from 1.5-2.5 mV (Gozariu et al., 1998; Yates et al., 2008). The H-reflex is a
longer latency response because the volley begins in the afferent fibers, as shown in
Figure 21. The response has to travel in both orthodromic and antidromic directions.
From Figure 22 below, the orthodromic and antidromic directions are shown by the
indicating arrows. The orthodromic direction is considered the normal direction and is
towards the axon terminal, and the antidromic direction is away from the axon terminal
(Tucker et al., 2005). The H-reflex measures the alpha motorneurons activated by Ia
afferents, and is seen when the peripheral nerve is stimulated by an electrical stimulation
(Lee et al., 2005) and evoked by muscle afferents (Reese et al., 2006; Yates et al., 2008).
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(Tucker et al., 2005)
Figure 21. Electrical stimulation of a mixed nerve. The mixed nerve contains Ia afferents
and motor neurons. Action potential within the mixed nerve is then evoked by an
electrical current depending on the thickness of the fibers in the nerve. Once the electrical
current is large enough to elicit the action potential in the nerve fibers, the potential
volley travels in both the orthodromic and antidromic directions to elicit the response
(Tucker et al., 2005).

Orthodromic

Antidromic

(http://nervecell-assesment.weebly.com/2d-labelled-diagram.ht)
Figure 22. A nerve cell that shows the directions of orthodromic and antidromic
directions.
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Human studies. Many studies have been conducted on human volunteers with
different spinal cord injuries along with different environments tested. A study conducted
by Nakazawa et al., 2006 compared the excitability stretch reflex of the soleus muscle in
patients with clinically complete and incomplete spinal cord injury, elderly healthy
patients, and young healthy patients. They mechanically and electrically induced stretch
reflex, H-reflex, and M-wave responses in electromyographic activity of the right soleus
muscle for all groups. Nakazawa et al. found that the incomplete spinal cord injury group
had a greater absolute stretch reflex electromyographic amplitude than its relative value
of the Mmax. The H/M ratio were comparable between the incomplete and complete
groups, but were greater than those in the younger and elderly groups (Figure 23 and 24).
Another study conducted by Phadke et al., 2007 compared the soleus H-reflex in
incomplete spinal cord injury patients in two different walking environments: treadmill
activity with body weight support and over ground walking. A total of 8 motor
incomplete spinal cord injury patients and 8 control patients were tested for their mean
soleus H-reflex amplitude. H/M ratio was recorded during mid-stance and mid-swing
phases of walking. The results showed that with manual assistance and body weight
support on the treadmill in stance phase, the H/M ratio was 33% smaller and swing phase
was 56% smaller than over ground incomplete spinal cord injury patients. The two
different walking environments of the control group did not change the soleus H-reflex
modulation significantly (Figure 25). Another study looked at the effects of sinusoidal
hip stretches on the soleus H-reflex modulation pattern in people with clinically
incomplete spinal cord injuries (Knikou et al., 2007). Seven clinically incomplete spinal
cord injury patients with lesions from cervical (C) 5 to thoracic (T) 11 participated in the
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study. The study showed that when a sinusoidal stretch is imposed, it started a hip-phase
dependent modulation of the soleus H-reflex (Figure 26). A study conducted by Phadke
et al., 2006 looked at the different H-reflex modulation with different percentages in leg
loading of the body weight support system in people with motor incomplete spinal cord
injuries. The study included 8 people with injury and 5 non-injured controls ranging
from 42-60 of age. Phadke et al. compared 0% (100% body weight load) and 40% (60%
body weight load) body weight support. The results showed that there was a significance
difference in the amplitude of the soleus H-reflex in the injured and non-injured group,
but no significance change was seen on the H/M ratios in either the injured/non-injured
groups with 0% or 40% body weight support. This study suggests that a 40% body
weight support load does not alter the soleus H-reflex excitability (Figure 27). The Hreflex is a very reproducible response, but not always the most accurate. Querry et al.,
2008 wanted to develop a model that was precise and accurate during the stimulation of
the H-reflex during specific times during the gait cycle using robotic body weight support
treadmill training in both patients with and without spinal cord injuries. This study used
the Lokomat system to determine the mid-stance and mid-swing points of the gait cycle.
The H-reflex of the soleus was synchronized to the mid-stance and mid-swing, and tested
at 1.8 and 2.5 km/h for 50 cycles. The results showed that the stimulation accuracy was
within 0.5° of the defined hip joint position, and >85% of the 50 H-reflex cycles met the
+/- 10% M-wave criterion that was determined during standing (Figure 28).
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(Nakazawa et al., 2006)
Figure 23. Summary of absolute peak-to-peak reflex electromyographic amplitude
(SRPP), absolute Hmax value, and Mmax of each subject group. Bar height show mean
and error bars represent the SEM. ANOVA indicated there were statistically significant
intergroup differences in the absolute reflex electromyographic amplitude, Hmax, and
Mmax. Abbreviations: CSCI, complete spinal cord injury; EC, elderly healthy subjects,
ISCI, incomplete spinal cord injury; YC, young health subjects. *Significant betweengroup differences revealed by Scheffé post hoc comparison (P<.05) (Nakazawa et al.,
2006).

(Nakazawa et al., 2006)
Figure 24. Summary of relative peak-to-peak stretch reflex sizes and H/M ratios for each
subject group. Bar height show mean and error bars represent the SEM. There were
statically significant inter-group differences in the relative peak-to-peak stretch reflex
sizes and H/M. *Significant (P<.05) between-group difference revealed by Scheffé post
hoc comparison (P<.05) (Nakazawa et al., 2006).
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(Phadke et al., 2007)
Figure 25. Persons with incomplete SCI: percentage decrease in H/M ratio while walking
in BWSMAT environment compared with unassisted overground environment. In
subjects 3 and 4, the H/M ratio increased in stance phase, and, in subjects 2 and 5, the
H/M ratio did not change in the swing phase of walking in the BWSMAT environment
(Phadke et al., 2007).
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(Knikou et al., 2007)
Figure 26. Characteristics of M-wave and H-reflex under control conditions and during
sinusoidal hip stretches. For each subject identified on the abscissa, the average control
H-reflex (A) and M-wave recorded during control conditions and following imposed
sinusoidal hip stretches (B) are illustrated as a percentage of the maximal M-wave.
Control H-reflexes varied from 18 to 35% of the maximal M-wave across subjects. The
M-wave was not statistically significantly different across experimental conditions
(P>0.05). In subject 11, the M-wave was not present at these stimulus intensities (Knikou
et al., 2007)
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(Phadke et al., 2006)
Figure 27. Standing i-SCI vs. non-injured control. Comparison of H/Mmax values
between the two BWL conditions in non-injured subjects with i-SCI. Standard error bars
shown (Phadke et al., 2006).
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(Querry et al., 2008)
Figure 28. M wave to H reflex response sensitivity graphs. Data represent tibial-nerve
stimulation ramping protocol from no M wave to maximal M wave amplitude (Mmax).
Presented are typical responses of subjects (a) without spinal cord injury (SCI), (b) with
American Spinal Injury Association (ASIA) A (motor complete) SCI, and (c) with ASIA
C (motor incomplete) SCI. Solid vertical line represents measured M wave that elicited
maximal H reflex (MHmax). Dotted vertical line represents +/-10% of MHmax percentage of
Mmax is calculated (Querry et al., 2007).
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Animal studies. There are several studies in animal models of spinal cord
injuries, most in contusion or weight drop spinal cord injury model at the T8/T9 level.
This is the most widely studied since it closely resembles the most common human spinal
cord injuries (Magnuson et al., 1999). In all animal models, except the complete
transection, the animals eventually regain most of their motor functions. This
phenomenon is not seen in humans, but is actually the opposite, where even a partial
injury to the spinal cord leads to spasticity. A negative aspect of the complete transection
model is that the animals need much more care after injury, and very often experience
complications. This is not to say that a complete transection model for animals is never
studied, but it is more common to see hemi-sections, partial transections, or contusion
injuries (Eaton, 2003).
A study conducted by Lee et al., 2005 studied how the severity of the spinal cord
injury affects the H-reflex at different times after injury. Four groups (Control, Mild
Contusion, Moderate Contusion, and Transection) of adult female Sprague-Dawley rats
were evaluated 1, 4, and 8 weeks after injury. The results showed that the H-reflex rate
depression was seen as abnormal in all three injured groups at each time period tested.
Week 8 is where the difference of more H-reflex rate depression was seen in the
transected group than those of the mild contusion group. The study also showed that the
baseline H-reflex amplitude was increased in the mild and moderate contusion group
(Figure 29, 30, and 31). This result was also seen in Nakazawa et al., 2006 outlined in
Section 3.3.3. A study conducted by Skinner et al., 1996 looked at the effects of exercise
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on the H-reflex in chronically spinalized adult rats. The rats underwent a complete spinal
cord transection at T10 level and were put on a training regimen for 3 months. The rats
received 60 minutes of motorized bicycle exercise training a day for 5 days per week.
Reflex testing took place after the 3 months of training occurred. The results of the Hreflex test showed that exercise training was capable of restoring frequency-dependent
depression of the H-reflex as in normal non-injured animals (Figure 32 and 33). A follow
up study to Skinner et al., 1996 was the “Restoration of frequency-dependent depression
of the H-reflex by passive exercise in spinal rats” conducted by Reese et al., 2006. This
study aimed to investigate the time frame of passive exercise that would have similar
outcomes as Skinner et al., 1996. Adult rats underwent a complete transection at the T10
level followed by motorized bicycle exercise training for 1 hour per day, 5 days per week
for either 15, 30, 45, 60, or 90 days. After training ended the H-reflex was tested. The
results of this study showed that after 30 days of exercise, statistically significant low
frequency-dependent depression of the H-reflex was seen. Overall there was a linear
decrease in low frequency-dependent depression of the H-reflex with passive exercise
(Figure 34, 35, and 36). A study by Yates et al., 2008 used a complete transection model
to assess the hyper-reflexia, a component of spasticity after injury. The study was able to
establish a time frame for the onset of the hyper-reflexia. They used adult rats that
underwent complete transection at T10 level and the H-reflex was tested at 7, 14, and 30
days’ post-transection. Results showed that the rats did in fact have spasticity in the form
of hyper-reflexia, and it was observed to decrease when tested at 10 Hz after 14 and 30
days. This study reports that between 7 and 14 days, the rats developed hyper-reflexia
(Figure 37 and 38).
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(Lee et al., 2005)
Figure 29. Changes in baseline H/M ratio after varying degrees of SCI. There was a
significant increase in baseline H/M ratio at 4 weeks after a Mild and Moderate SCI. Mild
injury continued to display an increased baseline H/M ratio at 8 weeks, although not
significantly different from controls. Transection SCI did not differ from controls at any
time points tested. At 8 weeks, transection SCI had significantly lower baseline H/M ratio
compared to Mild SCI. **P<0.01, * P<0.05 compared to controls unless noted otherwise.
Two-way ANOVA with Bonferonni post-test (Lee et al., 2005).

(Lee et al., 2005)
Figure 30. Overlapping representative H-reflex waveforms of uninjured control (A) and
4-week Mild SCI (B) animals measured at 0.1, 1 and 5 Hz stimulus frequencies. The
amplitude of the M-wave remains unchanged, while the H-wave amplitude steadily
decreases with increasing stimulus frequency. After SCI, this rate depression property of
the H-reflex is significantly diminished compared to uninjured controls. In addition, at 4
weeks after SCI, the baseline amplitude (0.1 Hz) is higher than uninjured controls (Lee et
al., 2005).
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(Lee et al., 2005)
Figure 31. Alteration of H-reflex rate depression over time after varying degrees of SCI.
Higher H/M percent values on the y axis indicates less H-reflex rate depression, whereas
lower values indicate more rate depression. H-reflex rate depression becomes more
abnormal over time after a mild SCI, but more normal after a transection (A). At 8 weeks,
mild injury displayed the most abnormal rate depression, while transection injury was
closest to controls. All three injury groups had significantly less rate depression
compared to uninjured controls at all three time points. Two-way ANOVA with
Bonferonni post-test. #P<0.05 comparing 8 weeks to 4 weeks, @P<0.05 comparing 8
weeks to 1 week, *P<0.05 comparing transected to mild (Lee et al., 2005).

46

(Skinner et al., 1996)
Figure 32. Averages of 16 consecutive responses following tibial nerve stimulation
recorded in plantar muscles in representative animals in each group. The earlier M-wave
(~ 2 ms latency) was followed by the H-reflex (~7 ms latency). Averages of stimulation
frequencies of 0.3 Hz and 10 Hz are superimposed for each animal. Note that the 10 Hz
average in the control record is decreased (due to frequency-dependent depression)
compared to the 0.3 Hz average (top left). On the other hand, the 10Hz average in the Tx
animal did not decrease as much compared to the 0.3 Hz average (top right). The 10 Hz
averages in both treated animals, Tx + FSCI and TX + EXER (bottom left and right)
decreased as in the control animal. Calibration bar 2 ms for all records (Skinner et al.,
1996).
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(Skinner et al., 1996)
Figure 33. Graph of the mean and standard deviation of the H-reflex at 1 Hz, 5 Hz and 10
Hz stimulation frequency as a percent of the response observed at 0.3 Hz stimulation
frequency. Animals in the CTL group (square) showed marked decrease of the H-reflex
amplitude as the stimulation frequency increased. After transection (Tx, diamond), there
was decreased habituation of the H-reflex at 10 Hz (asterisk, P<0.01) compared to the
CTL as well as the two treatment groups (Tx + RCI, circle: Tx + EXER, triangle)
(Skinner et al., 1996).
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(Reese et al, 2006)
Figure 34. Averages of H-reﬂex recordings. Evoked muscle potentials included an early
M-wave and a later H-reﬂex following stimulation. (a) Averaged responses to stimulation
at 0.2Hz in a control rat. (b) Averaged responses to stimulation at 10Hz in the same
control rat. Note the decrease in amplitude (frequency-dependent depression) of the Hreﬂex at 10Hz compared to 0.2Hz. (c) Averaged responses to stimulation at 0.2Hz in a Tx
only 60D rat. (d) Averaged responses to stimulation at 10Hz in the same Tx only 60D rat.
Note the greater amplitude (decrease in frequency-dependent depression) of the H-reﬂex
at this frequency compared to 10Hz in the intact animal (b). (e) Averaged responses to
stimulation at 0.2Hz in a Tx +Ex 60D rat. (f) Averaged responses to stimulation at 10Hz
in the same Tx + Ex 60D rat. Note the return of frequency-dependent depression of the
H-reﬂex after 60 days of MBET. Calibration bars vertical 0.5mV, horizontal 2ms (Reese
et al., 2006).
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(Reese et al., 2006)
Figure 35. H-reﬂex amplitude at 0.2, 1, 5, and 10Hz for intact animals (control, open
circles), and 15 (Tx + Ex 15D, ﬁlled diamonds), 30 (Tx + Ex 30D, ﬁlled circles), 45 (Tx
+ Ex 45D, ﬁlled triangles), 60 (Tx + Ex 60D, ﬁlled plus signs) and 90 (Tx + Ex 90D,
ﬁlled squares) days of MBET, and 90 days without MBET (Tx only 90D, open squares).
Frequency-dependent depression of the H-reﬂex at 0.2Hz was designated 100%, and all
statistical comparisons in this ﬁgure made against the Tx only 90D group. At 1Hz, the Tx
only 90D group (*) diﬀered signiﬁcantly from the Tx + Ex 45D, Tx + Ex 60D, and
control groups at the P<0.05 level (+); and from the Tx + Ex 30D group at the P<0.01
level (++). At 5Hz, the Tx only 90D group (*) diﬀered from the Tx + Ex 45D, and Tx +
EX 60D groups at the P<0.05 (+), and was also diﬀerent (**) from the Tx + Ex 30D and
control group at the P<0.01 level (++). At 10Hz, the Tx only 90D group (*) diﬀered from
the Tx + Ex 45D group at the P<0.05 level (+), and diﬀered (**) from the Tx + Ex 30D,
Tx + Ex 60D, Tx + Ex 90D, and control groups at the P<0.01 level (++) (Resse et al.,
2006).
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(Reese et al., 2006)
Figure 36. H-reﬂex amplitude at 0.2, 1, 5, and 10Hz for control (open circles), 30 days
without MBET (Tx only 30D, ﬁlled squares), and 30 days with MBET (Tx + Ex 30D,
ﬁlled diamonds). Frequency-dependent depression of the H-reﬂex at 0.2Hz was
designated 100%, and all statistical comparisons in this ﬁgure made against the Tx only
30D group. At 1Hz, the Tx only 30D group (*) diﬀered from the Tx + Ex 30D group at
the P<0.05 level (+), but not the control group. At 5Hz, the Tx only 30D group (*)
diﬀered from the Tx + Ex 30D group at the P<0.05 level (+) and from the CONTROL at
the P<0.01 level (++). At 10Hz, the Tx only 30D group (*) diﬀered from the Tx + Ex 30
group at the P<0.05 level (+), and from the control at the P0.01 level (++) (Reese et al.,
2006).

51

(Yates et al., 2008)
Figure 37. (a) Representative H-reflex recordings of animals tested 7 days after
transection (Tx). The H-reflex was observed 8–10ms after the stimulus. The H-reflex
amplitudes at the different frequencies have been superimposed for comparison. The
black line represents the H-reflex recorded at 0.2Hz. The dark gray line represents
recording at 5Hz, and the light gray line represents recording at 10Hz. Note the decrease
in amplitude as frequency of stimulation was increased, indicative of low frequencydependent depression present at 7 days post-Tx. (b) Representative H-reflex recording of
animals tested 14 days after Tx. The H-reflex responses at the different frequencies have
been superimposed for comparison. The black line represents H-reflex recorded at 0.2Hz.
The dark gray line represents recording at 5Hz, and light gray line represents recording at
10Hz. Note lack of decrement in amplitude as frequency of stimulation was increased,
indicative of a decrease in frequency-dependent depression. The x-axis represents time in
milliseconds, the y-axis amplitude in millivolts (Yates et al., 2008).
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(Yates et al., 2008)
Figure 38. H-reflex amplitude at 0.2, 1, 5 and 10Hz in intact (control, filled circles), Tx
7D (squares), Tx 14 D (diamonds) and Tx 30D (triangles) groups. The y-axis shows
amplitude expressed as a percent of the amplitude at 0.2Hz designated as 100 percent,
and all statistical comparisons in this figure were made against the control group. At 5Hz,
the Tx 14D and Tx 30D groups differed from the control group and the Tx7D (P<0.05).
At 10Hz, the Tx 14 D group differed from the control group and Tx 7D (P<0.05), and the
Tx 30 D group differed from the control and Tx7D group (P<0.01). *indicates P<0.05;
**indicates P<0.01. Note the lack of habituation of the H-reflex at 10Hz in the Tx 14D
and Tx 30D groups compared with the control group and the Tx 7D group. Tx,
transection (Yates et al., 2008).
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Chapter 4
Therapeutic Approaches to Treat Spasticity in Spinal Cord Injury
Rehabilitation
Body weight-support treadmill training (BWSTT). Body weight-support
treadmill training focuses on re-training standing and walking in patients with spinal cord
injury (Phadke et al., 2006; Querry et al., 2008) by producing a repetitive stepping pattern
like that of normal walking (Phadke et al., 2007). There are two parts to this
rehabilitation, namely the body weigh-support system and the treadmill. The body weighsupport system allows a particular percentage of patient’s body weight to be supported by
a suspended device and harness taking pressure and weight off the legs. This system is
suspended over a treadmill so the patient can walk with either manual or robotic help
(Phadke et al., 2006). The robotic system is very beneficial for researchers and clinicians
because it allows them to be able to monitor joint position, torques, and the overall
performance of the patient with better accuracy and precision. This robotic training also
gives a better monitored environment allowing the patients’ monosynaptic reflex to be
measured through H-reflex during standing and stepping, allowing assessment of the
improvement throughout the body weigh-support treadmill training process. (Querry et
al., 2008). After training, spasticity should normalize, which is evident by the observed
changes in the H-reflex, such as the H-wave becoming more sensitive to a reapplied
electrical stimulation (Knikou et al., 2007). Another benefit of body weight-support
treadmill training that are typically not discussed are the physiological and psychological
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benefits for patients. They can improve the overall health of the patient, not just the
spinal cord injury (Hicks et al., 2008).
Functional electrical stimulation (FES). Functional electrical stimulation (FES)
has always been used in orthopedic and neurological rehabilitation, and is now being
used for spinal cord injuries. This rehabilitation can have a therapeutic or functional
effect. This section will focus on the therapeutic effects only. The ultimate goal of using
FES is to reduce muscle spasms and the effects of spasticity by obtaining responses in the
nervous system. During FES, a low level of electrical current is applied to a paralyzed
nerve or muscle via, an electrode controlling the neural activation, in hopes to restore or
achieve function. FES is typically combined with some form of physical activity such as
cycling. Cycling will be discussed more in the next section (Martin et al., 2012; Peckham,
1989). Studies have shown that functional electrical stimulation by itself, used with
incomplete and complete spinal cord injury patients, causes an increase in stepping
response and an activation of the central pattern generator mechanism. Patients when
regularly treated also show improvement in motor and sensory scores and decrease in
spasticity (Martin et al., 2012).
Cycling. Cycling movements is another rehabilitation strategy that is used in
spinal cord injuries. It is a passive exercise that helps to maintain full range of motion of
the joints that are immobilized (Kakebeeke et al., 2005; Rayegani et al., 2011). Studies
have shown that it can reduce spasticity in patients as well as cardiac output and stroke
volume, and muscle atrophy (Rayegani et al., 2011). Cycling is sometimes preferred over
body weight-support treadmill training if researchers are studying the H-reflex, because it
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can allow them to see all the muscles being activated. Also changing the load can
increase or decrease the levels of muscle activation (Boorman et al., 1992). One study
conducted by Reese et al., 2006 used motorized bicycle exercise training to measure
hyper-reflexia by restoring the frequency-dependent depression of the H-reflex. They
used a complete spinal cord transection model with rats that underwent training for 1
hour per day, 5 days per week for 3 months and were then tested at 15, 30, 45, 60, and 90
days after training began. The results showed that after 30 days of exercise there was a
statistically significant low frequency-dependent depression of the H-reflex.
Transplant
Cell-based therapies. Stem-cell therapies have many of the qualities necessary to
promote regeneration in spinal cord injuries, and are widely studied because of their
differentiation potential (Assuncão-Silva et al., 2014). For these therapies to be successful
in spinal cord regeneration they need to 1) minimize the secondary injury, 2) replace and
minimize the survival of damaged cells and 3) alter the local environment to be more
conducive for regeneration (Sabapathy et al., 2015; Tam et al., 2014). Combining stemcell with growth factors allows a strategy to control cell fate after transplantation (Tam et
al., 2014). Some transplantation strategies have been tested more than others and
investigated through clinical trials. This research, though, has not yet shown a clear
convincing pattern in the results of significantly promoting regeneration in spinal cord
injuries. Additional studies are needed to safely and efficiently use stem-cell therapies as
a possible treatment for spinal cord injury (Assuncão-Silva et al., 2014). Stem-cells that
are being studied include: embryonic, induced pluripotent, neural, mesenchymal, and
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glial cells, which will be discussed in the upcoming sections (Assuncão-Silva et al., 2014;
Tam et al., 2014).
Embryonic stem cells (ESC). Embryonic stem cells (ESC)are pluripotent cells
(Tam et al., 2014) that can differentiate into more than 200 different fetal cell lineages
(Tewarie et al., 2008; Assuncão-Silva et al., 2014). These cells are present within the
inner cell mass of the blastocyst, which is formed very early on in development (Tewarie
et al., 2008). Many studies have been conducted to look at ESC and their ability to
specifically differentiate into neural and glial cells. Neural and glial cells and their roles
in spinal cord injury repair are discussed more in later Sections 4.2.4 and 4.2.6
(Assuncão-Silva et al., 2014). Through the different studies using a spinal cord injury
model it has been shown that ESC offer good long-term treatments because of their
ability to survive in the injured spinal cord (Tewarie et al., 2008). A study conducted by
Keirstead et al., 2005 used human ESC that were differentiated into oligodendrocyte
progenitor cells (a subtype of glial cells) and were implanted into the injury site of the
spinal cord either 7 days or 10 months after injury. This study showed that the rats with
the transplant of cells after 7 days had recovery of motor function whereas the rats with
transplant after 10 months did not. The overall outcome of this study claims that
embryonic stem cell have therapeutic potential with a time frame limitation in which
these cells can be therapeutic.
Induced pluripotent stem cells (iPS cells or iPSCs). Induced pluripotent stem
cells (iPSCs) are another type of stem cell that can be obtained directly from adult tissues
and used for autologous transplantation. They are obtained by reprogramming
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differentiated adult cells through the introduction of 4 transcription factors (OCT3/4,
SOX2, KLF4, and MYC) that revert them to an embryonic stage (Assuncão-Silva et al.,
2014; Tam et al., 2014; Tewarie et al., 2008). They are similar to embryonic stem cells in
their characteristics, such as pluripotency, self-renewal capacity, and gene expression
(Assuncão-Silva et al., 2014). Researchers are looking into using iPSCs instead of
embryonic stem cells because of the ethical issues that are associated with them later
(Tewarie et al., 2008). iPSCs are useful because they run no risk of immune rejection of
transplants. A potential problem is the formation of tumors. Tumor formation in induced
pluripotent has been widely studied and is now being studied for the use of cellular
system for spinal cord injury treatment. One study implanted human induced pluripotent
stem cells derived neurospheres (hiPSC-NSs) into non-obese diabetic-severe combined
immunodeficient (NOD-SCID) spinal cord injury model mice. There was an
improvement of the functional activity of the mice, because there was evidence of
formation of synapses between the cells and the neurons, increased in the expression of
neurotrophic factors, angiogenesis, axonal regrowth and myelination of the injury site.
This evidence was prominent because the cells differentiated into neurons, astrocytes,
and oligodendrocytes. There was also no tumor formation reported. Another study that
was conducted in 2012 used pre-evaluated neural stem/progenitor cells (NS/PCs) clones
that were derived from both mice and human induced pluripotent stem cells. The model
used a contusion spinal cord injury in nonhuman primates. Similar results of cell survival
and differentiated into neurons, astrocytes, and oligodendrocytes, were seen without
evidence of tumor formation. The results were also promising with axonal
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sparing/regrowth and angiogenesis at the injury site and functional recovery of the animal
(Assuncão-Silva et al., 2014).
Neural/progenitor stem cells (NSPCs). Neural/progenitor stem cells (NSPCs) are
used in spinal cord injuries because they are multipluripotent and found in the central
nervous system, and offer neuroprotection and axon regeneration properties. These stem
cell are unique because they have been found to have the ability to differentiate into the
three main neural cell linkages: neurons, oligodendrocytes, and astrocytes (AssuncãoSilva et al., 2014; Tam et al., 2014; Tewarie et al., 2008). NSPCs have been tested in
many spinal cord injury models including contusion, traumatic, and complete injury with
promising results (Assuncão-Silva et al., 2014). In contused adult rat model, the NSPCs
were found to produce neurons that travel along the spinal cord. This also resulted in
improvement in the patient’s overall function (Kakulas, 2004). The study using a cervical
contusion-induced spinal cord injury showed that human NSPCs can survive and
eventually differentiate into the four neural cell linkages. It was reported that there was a
decrease in the injury site, and also an increase in motor activity of the animals (Iwanami
et al., 2005). In a transection spinal cord injury model of rats, fetal neural stem cells were
implanted. After two months, the cells were found to form ectopic colonies. These
colonies were seen dispersing into the CNS where they were dividing into several neuralcell lineage types (Lu et al., 2012). They secreted a variety of molecules that had the
potential to protect cells from death, and also secrete neurotrophic factors. Both in in
vitro and in vivo tests, the secretion of growth factors that the NSPCs give off was found
to promote growth of the host axons, which are sensitive to neurotrophic factors. More
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testing has shown that combinational treatment of these NSPCs, and the growth factor
neurotrophin-3 (NT-3), offer extremely promising results by expanding the growth and
penetration of host axons along the injury site (Assuncão-Silva et al., 2014; Tewarie et
al., 2008). More on combinational treatment will be discussed in Section 4.4. These
NSPCs were studied in 2011 in a phase I/II clinical trial by a company in Switzerland.
This company specifically used purified fetal human neural stem cells (HuCNS-SC) for
the treatment of chronic thoracic spinal cord injury in both complete and incomplete
patients. The clinical trial used a total of 12 patients, 7 of them having complete injuries
and 5 incomplete. Results were only reported for 8 of the 12 patients. 4 of the complete
injury patients showed a significant improvement in sensory function. Two patients with
incomplete injuries gained sensory perception, and the third remained altered (AssuncãoSilva et al., 2014).
Mesenchymal stromal stem cells (MSCs). Mesenchymal stromal stem cells
(MSCs) were first thought to be only present within bone marrow, but are also found in
non-marrow tissue. These cells are multipotent and can differentiate into osteoblasts,
chondrocytes and adipocytes in vitro (Assuncão-Silva et al., 2014; Tam et al., 2014). The
advantage of using (MSCs) is that they are more available because they can be found in
multiple tissues. There are no ethical or political issues during the isolation process
(Assuncão-Silva et al., 2014).
The use of MSCs and different strategies have been studied, but there is not yet a
clear census of the outcomes. Some of the outcomes reported are that in vitro bone
marrow mesenchymal stromal stem cells (BM-MSCs) differentiate into neuron-like cells
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and glial cells, and in vivo they migrate across the blood-brain barrier, repopulate the
CNS, and differentiate into microglia-like cells. Researchers are interested in their trophic
activity rather than strictly using them as a therapeutic agent. MSCs secrete a set of
bioactive molecules and/or microvesicles, which is called secretome. This secretome is
thought to have neuroprotection and axon regeneration properties after spinal cord injury
by suppressing local immune response, enhancing angiogenesis and inhibiting scarring
and cell apoptosis (Assuncão-Silva et al., 2014). This process can be seen in Figure 39.
When specifically looking at spinal cord injury treatment, MSCs are used in two
different ways: transplantation of the cells into the injury site and administration of
secretome. Many studies have been conducted for transplantation of the MSCs using
either intravenous or subcutaneous injections, as well as direct injection into the injury
site. All of these studies using these different techniques showed functional recovery after
spinal cord injury. Studies using administration of the secretome also showed promising
results. (Assuncão-Silva et al., 2014).
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(AssuncãoSilva et al., 2014)
Figure 39. Application of mesenchymal stromal stem cells (MSCs) as a treatment for
spinal cord injury. The MSCs secretome is believe to be a key player on the promotion of
neuroregeneration and neuroprotection, as well as the modulation of the inflammatory
response (Assuncão-Silva et al., 2014).

Glial cells.
Olfactory ensheathing cells (OECs). Olfactory ensheathing cells (OECs) are used
in spinal cord injury repair because studies have shown functional recovery after
transplantation. These cells are a specialized glial cell found in the olfactory system. The
cells have been shown to promote axonal regeneration of olfactory nerve fibers into the
olfactory bulb of the CNS, serving as a pathway for regeneration of the olfactory receptor
neurons, by creating cellular channels that the axon can grow through (Assuncão-Silva et
al., 2014; Radtke et al., 2008). They can prevent axons from recognizing growth
inhibitory molecules, and this allows them to elongate into otherwise inhibitory terrain
(Tewarie et al., 2008). Additionally, they can produce different neurotrophic factors
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(Radthke et al., 2008), including nerve growth factor (NGF), brain-derived neurotrophic
factor (BDNF), neuregulins, and glial cell line-derived neurotrophic factor (GDNF)
(Assuncão-Silva et al., 2014). Olfactory ensheathing cells have been tested in phase I/II
clinical trials in complete thoracic injuries and severe chronic spinal cord injuries. In the
complete thoracic injuries clinical trial, the safety and feasibility was first tested. The
results showed that, after one and three years, there were no safety issues observed with
the procedure, no cord cyst or tumor formation, no neuropathic pain and deterioration in
neurological status, and finally no functional changes in the patients. In the phase I/II
pilot clinical study with severe chronic spinal cord injury patients, olfactory mucus
autographs were transplanted. Results showed motor improvements in 11 of the 20, with
some complications in 5 of the patients (Assuncão-Silva et al., 2014).
Schwann cells (SCs). Schwann cells (SCs) are another form of glial cells just like
the OECs, but they are primarily found in the PNS. These cells have become of more
interest in spinal cord injuries because they may allow damaged axons in the central
nervous system to regrow and remyelinate, just as it does in the PNS. Many studies have
been conducted, but their results are contradictory. Some report that in the presence of
astrocytes, the Schwann cells are not sustainable, but then some reports show evidence in
their ability to promote regeneration. Some of the studies that support the evidence that
they can promote regeneration involve transplantation of autologous SCs into thoracic
injuries of cat spinal cord, human SCs grafted in a transected nude rat spinal cord, and
adults SCs in a moderately contused adult rat thoracic spinal cord. These SCs, just like
the OECs, have the unique property to overexpress NGF or BDNF. These genetically
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modified SCs have shown a tremendous increase in axonal growth and remyelination
after transplantation into adult rats with spinal cord injuries. Since there have been
promising outcomes in the animal SCI models, it has been translated over to clinical
trials. One study used autologous transplantation of SCs into patients with chronic spinal
cord injuries. They injected the cells directly into the lesion by intramedullary delivery.
The results showed no harmful effects after one and two years, and no real benefits were
observed in the patients. This study ultimately showed that there is no danger associated
with the procedure. In 2013, the Miami Project to Cure Paralysis performed the first ever
FDA approved SC transplantation into a patient with complete thoracic spinal cord
injury. This was a phase I clinical trial to test the safety and the ability to transplant the
patient’s own SCs. Four weeks after injury the cells were transplanted into the patient and
no adverse signs were reported. The next part of the phase I clinical trial enrolled 8 more
patients with acute thoracic spinal cord injuries and is currently ongoing (Assuncão-Silva
et al., 2014).
Hydrogel-based biomaterials. Hydrogel-based biomaterials have gained interest
in spinal cord research. While using hydrogels for drug and cell delivery to the central
nervous system, which is composed of the brain, spinal cord, and retina, there are many
properties that need to be taken into consideration. Some of which include
physicochemical and mechanical properties, biodegradability/bio absorbability, and
biocompatibility. Some of these properties can be seen in Table 4.1 below. Since
hydrogels possess these properties, they are an excellent candidate for neural tissue
repair. In the upcoming sections, synthetic and natural-based hydrogels are outlined, and
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the role they play within spinal cord injury research is discussed (Assuncão-Silva et al.,
2014; Tam et al., 2014).

(Tam et al., 2014)
Figure 40. Hydrogel properties considered relevant for drug and cell delivery to the
central nervous system (Tam et al., 2014).

Synthetic hydrogels. Synthetic hydrogels have one main advantage of being able
to be manipulated to have specific mechanical and physicochemical properties
(Assuncão-Silva et al., 2014; Kim et al., 2014). It is also easy to blend two or more of
these different synthetic polymers to create something unique with the specific properties
needed. A set back that comes with these synthetic hydrogels is the fact that they are
capable of producing an immune response within the body, and therefore have limitations
with the FDA approval (Kim et al., 2014).
Poly (lactic acid) (PLA). Poly-lactic acid (PLA) is a biodegradable aliphatic
polyester, and is a member of the α-hydroxy acid class of compounds. Its chemical
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structure is shown in Figure 40 (Assuncão-Silva et al., 2014; Kim et al., 2014). A
disadvantage of PLA is that it is structurally unstable, fragmenting and collapsing on
itself. Even with the instability it has shown that it supports axon extension and vascular
growth into the graft. PLA scaffolds are used as only a temporary extracellular matrix.
Implanting PLA alone, either in a hydrogel, macroporous sponge, micro- or nano-fiber or
multi-walled conduit forms showed promising results. The next logical step would to be
to combine the poly-lactic acid with a therapeutic drug to improve the outcome. Through
the research, there has not been a clear result for successful axonal regeneration in animal
spinal cord injuries. Much more research is needed to optimize the results (Kim et al.,
2014).

(Mahapatro et al., 2011)
Figure 41. Chemical Structure of poly (lactic acid) (PLA).

Poly (lactic-co-glycolic acid) (PLGA). Poly-lactic-co-glycolic acid (PLGA) has
been approved by the FDA for the repair of human peripheral nerves. It is now being
researched for use in the CNS related injuries including spinal cord injuries. PLGA is a
polymer made up of two different monomers; glycolic acid (Figure 42, X) and lactic acid
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(Figure 42, Y). The degradation and mechanical properties of this synthetic hydrogel can
be varied depending on its particular application, by varying the ratio of the monomer
units and their stereochemistry (either D- or L-form), along with varying the molecular
weight distribution of the monomer chains (Assuncão-Silva et al., 2014; Kim et al.,
2014).
PLGA has evolved throughout the years in relation to how it’s being used. It
initially started off as a delivery agent of neurotrophic factors in tissue engineering
(Assuncão-Silva et al., 2014) and has evolved into a microsphere for drug delivery.
Today it is a nanoparticle that encapsulates different therapeutic drugs. Some of the more
recent studies of PLGA involve the delivery of certain stem cells, such as MSCs, neural
stem cells and SCS. In a rat hemisection injury model, a PLGA scaffold containing neural
stem cells showed a major improvement in spinal cord function, and in a canine model it
showed that there is a possibility for spinal cord regeneration. In a rat complete
transection model, PLGA hydrogels, loaded with human MSCS, showed improvement in
both behavior analysis and motor-evoked potentials (MEP’s). PLGA definitely has the
potential in spinal cord injury repair, but needs to be studied more extensively (Kim et al.,
2014).
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(Mahapatro et al., 2011)
Figure 42. Chemical structure of poly (lactic-co-glycolic acid) (PLGA). X and Y
represent the number of lactic acid and glycolic acid respectively (Mahapatro et al.,
2011).

Methacrylate-based hydrogels.
Poly [N-2-(hydroxypropyl) methacrylamine] (PHPMA). Poly [N-2(hydroxypropyl) methacrylamide] (PHPMA) is a hydrophilic co-polymer, that has
neuroinductive and neuroconductive effects, and the chemical structure is shown in
Figure 43. There currently is a PHPMA hydrogel, that was developed for spinal cord
injury, commercialized today. The hydrogel is known as NeuroGel™, and it contains
PHPMA with an Arg-Gly-Asp (RGD) modification. (Kim et al., 2014). Throughout the
years researching PHPMA, the results were extremely promising. In a transected rat
spinal cord model, the hydrogel was found to successfully bridge the gap at the site of
transection (Assuncão-Silva et al., 2014). The hydrogel also helped with cell growth,
angiogenesis and axonal growth, all within the microstructure of the spinal cord. This
study also concluded that the growth of reparative tissue containing glial cells, blood
vessels, axons, dendrites, and extra cellular matrix molecular (Assuncaão-Silva et al.,
2014; Kim et al., 2014) was present and favored. Other studies have also reported
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reduction of necrosis, motor benefits and improved locomotor BBB scores (AssuncãoSilva et al., 2014).

(Ulbrich et al., 2010)
Figure 43. Chemical Structure of poly [N-2-(hydroxypropyl) methacrylamide (PHPMA).

Poly 2-hydroxyethyl methacrylate (PHEMA)/poly 2-hydroxyethyl methacrylateco-methyl methacrylate (PHEMA-MMA). Poly 2-hydroxyethyl methacrylate (PHEMA)
hydrogel is made up of hydrophilic co-polymer that are cross-linked networks. The
chemical structure is shown in Figure 44. This hydrogel is able to absorb water and retain
it without dissolving, which provides a 3D substrate for cell attachment and growth. It is
a known fact that most synthetic hydrogels are not biodegradable but this PHEMA
hydrogel is ideal in tissue engineering because it has ideal physical properties and is very
biocompatible (Assuncão-Silva et al., 2014; Kim et al., 2014). An interesting property
that PHEMA has is that when it is being produced into a hydrogel, it can be made to have
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similar mechanical properties of the spinal cord. The more similar they are, the least
likely issues are to arise after implantation (Kim et al., 2014).
Kim et al., 2014 studied both PHEMA and its co-polymer PHEMA-MMA and
reported that they promoted axon regeneration. The hydrogels were then modified to
obtain better mechanical strength and function by adding coiled channels (AssuncãoSilva et al., 2014; Kim et al., 2014). The surface of the hydrogels were either positively
charged or negatively charged. Results showed that the positively modified hydrogels
were better at promoting axon growth and regeneration than both the unmodified or
negatively charged hydrogels. More recently, studies have been done to access the
capability of using PHEMA and its co-polymer PHEMA-MMA to deliver therapeutic
cells. One study used PHEMA with MSCs in a hemisected rat spinal cord model. The
results showed that it promoted regeneration of the axons (Kim et al., 20114).

(Morita, 2014)
Figure 44. Chemical structure of poly (2-hydroxyethyl methacrylate) (PHEMA).

Poly (ethylene glycol) (PEG). Polyethylene glycol (PEG) shown in Figure 45 is a
synthetic hydrogel used in many aspects of spinal cord injuries. It is a water-soluble
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nontoxic polyether that is known to have protective effects on the spinal cord by resisting
protein adsorption and cell adhesion (Assuncão-Silva et al., 2014; Kim et al., 2014).
These protective effects allow a PEG hydrogel to be injected into the body without the
body producing an immune response. As stated before, PEG has a natural effect on the
spinal cord, so researchers started to develop different cross-links using PEG. Different
cross-links were created to increase/decrease degradation rate and increase cell adhesion
(Assuncão-Silva et al., 2014).
PEG has a wide range of uses as a biomaterial. Studies have shown promising
outcomes. An in vivo model using just a PEG solution injection into a spinal cord injury
showed potential for accelerating and enhancing the membrane resealing process, and
also restoring neuronal membrane integrity (Assuncão-Silva et al., 2014). Another study
reported that cross-linked PEG with poly (N-isopropylacrylaminde) (PNIPAAAm) in to a
spinal cord injury allowed axonal growth and successful cell transplants or BDNF release
(Kim et al., 2014). Another study looked at the effects of using PEG hydrogel loaded
with NT-3, which was implanted into a rat model of spinal cord injury. Results from this
study showed that there was an improvement in the rat’s locomotor behavior and more
axonal growth (Assuncão-Silva et al., 2014). In our study, we used a combination of the
cross-linked PEG and PNIPAAAm loaded with BDNF and NT-3. In Chapter 5, the
results of the study will be discussed.
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(Barron, 2015)
Figure 45. Chemical structure of poly (ethylene glycol) (PEG).

Natural-based hydrogels. Natural-based hydrogels are commonly made up of
natural polymers (e.g. Proteins) and/or molecules that are naturally found within the
human body, because it is easier for integration and interaction with the tissue already
present. Most of the natural-based hydrogels are substances that are found within the
bodies extra cellular matrix or have existing properties of the cells. This gives the
hydrogel a seamless integration into the injury site. Another unique trait is that these
hydrogels have similar properties of the soft tissue that they are replacing within the
spinal cord. One problem, though, of the natural-based hydrogels is the chance for
immune reactions from the existing tissue because they are derived from natural sources
(Assuncão-Silva et al., 2014; Kim et al., 2014).
Agrose. Agrose is a linear polysaccharide of D-galactose and 3,6-anhydro-Lgalactopyranoe (Figure 46) that is derived from the cell walls of red algae making it
biocompatible. It is used in three different varieties as a delivery vehicle for drug or
macromolecules in animal models of spinal cord injuries; encapsulation, tubular, and
hydrogel. This section will focus on the hydrogel. One of the main applications of agrose
hydrogel is local delivery of BNDF because of the porous nature of the structure and
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mechanical properties similar to that of the tissue. One trait that intrigues researchers to
study agrose hydrogel as a tissue engineering approach for spinal cord repair is their
ability to polymerize in situ thereby adapting to the different shapes of lesion because of
their ability to fill different types of neurological defects.
Previous studies involving agrose hydrogels have already proven the potential
uses for them because of their ability to support neurite extension in vivo. In a contusion
and dorsal-over hemisection rat model of spinal cord injuries, the agrose hydrogels
loaded with methylprednisolone nanoparticles were able to provide a local and gradual
release of the drug. The results showed that the lesion volume was reduced, as well as a
decreased in the expression of proinflammatory proteins when compared to systematic
methylprednisolone delivery. Another study used the agrose hydrogel delivery system to
deliver lipid microtubes that have been loaded with different drugs. The main drug used
was thermostabilized chondroitinase ABC (chABC) (Assuncão-Silva et al., 2014; Kim et
al., 2014). Over time, the chondroitinase ABC was released and showed an improvement
in reducing the deposition of chondroitian sulfate proteoglycans (CSPGs) (CSPGs are a
major class of axonal growth inhibitors) and eliminating the use pumps or catheters
(Assuncão-Silva et al., 2014). It is also shown that if these agrose hydrogels containing
chondroitinase were combined with NT-3 that there was locomotor recovery with axonal
regeneration in injured rats (Kim et al., 2014).
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(National; CID=11966311).
Figure 46. Chemical structure of Agarose.

Alginate. Alginate is also a linear polysaccharide like agarose that is derived from
the cell walls of brown algae and is composed of repeating structures of (1-4) linked β-Dmannuronate acid (Figure 47, M) and α-L-guluronate acid (Figure 47, G). This
polysaccharide has both biocompatibility and bioresorption properties, which allows it to
be used in cell encapsulation, cell transplantation, and tissue engineering (Assuncão-Silva
et al., 2014; Kim et al., 2014). In a transection spinal cord injury model of young rats, the
alginate provided a pathway for the severed axons and also decreased astrocytosis
between the alginate and the spinal cord (Kim et al., 2014). In an acute cervical spinal
cord of adult rats, the alginate was found to promote axon regeneration across the
scaffold (Assuncão-Silva et al., 2014). One issue that occurs with using this natural
alginate is that it has a high degradation rate and cytotoxicity, and mammals do not
possess the correct enzymes to degrade high molecular polymers of alginate. The
addition of poly (lactic-co-glycolic acid) (PLGA) microspheres allows for a controlled
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environment for enzymatic degradation (Assuncão-Silva et al., 2014; Kim et al., 2014).
Another point to be aware of when using natural alginate is that they include toxic
impurities and have to go through an extensive ultra-purification process before it is
transplanted within the body safely (Kim et al., 2014).

Figure 47. Chemical structure of alginate.

Collagen. Collagen is a protein found within the extra cellular matrix of mammals
and accounts for about 25-30% of the total proteins. There are a total of 29 different
collagen types. Collagen is used as a natural based hydrogel because of its binding sites
that are used for cell adhesion, cell migration, proliferation, differentiation. They are also
biocompatible, biodegradable, and noncytotoxic (Assuncão-Silva et al., 2014; Kim et al.,
2014). When looking at the mechanical properties of collagen, it has a very high
mechanical strength that is closely related to that of soft tissue (Kim et al., 2014). One
aspect of collagen that makes it easier to produce a hydrogel is that the gel formation can
be produced by just changing the pH balance. Collagen is not only used in spinal cord
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injuries, but in burns, wound dressings and nerve regeneration. There have been many
studies conducted on different models using neurotrophic factors, among others, to
deliver therapeutic cells. A recent study conducted in 2014, used collagen hydrogels as a
vessel for the delivery of NT-3 in spinal cord injury rats. The results showed an aligned
axonal regeneration, and an increase in the number of regenerating axons were observed
in the vessels delivering the neurotrophin-3 (Assuncão-Silva et al., 2014).

(Shoulders et al., 2009)
Figure 48. Collagen triple helix structure.

Fibrin. Fibrin is a fibrous protein that is involved during the clotting process of
our body and acts as a binding agent between the molecules. It is produced during the
coagulation process where fibrinogen has been severed by thrombin producing fibrin
monomers. The process of fibrinogen and fibrin formation during the coagulation process
is shown and explained in Figure 49 (Assuncão-Silva et al., 2014; Kim et al., 2014).
When fibrin is used in hydrogels for tissue engineering, it poses some advantages and
disadvantages. One of the advantages is that the gelation of the hydrogel can be
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controlled through different concentrations of thrombin during the coagulation process,
offering researchers the possibility to maintain a liquid hydrogel during injection and
once in the body a solid hydrogel. But on the other hand, these fibrin hydrogels
originating from mammals degrade rapidly, posing a problem with contamination from
blood-derived pathogens or prion proteins, and some studies report that inhibits neurite
outgrowth and activates scar formation (Assuncão-Silva et al., 2014). Despite these
disadvantages, fibrin hydrogels have still been tested and showed promising results.
Studies have been conducted on subacute, hemisected and severe, among others, using
different growth factors, and stem cells, and all have shown some type of improvement,
whether it be an increased neural fiber sprouting or some degree of axonal growth. Fibrin
hydrogels have a very promising future in spinal cord injuries because they have the
greatest potential for a minimally invasive approach for patients (Assuncão-Silva et al.,
2014; Kim et al., 2014).
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(Undas et al., 2011)
Figure 49. Fibrinogen and fibrin formation. Fibrinogen is composed of 2Aα, 2Bβ, and
2γ-chains, which are arranged in a dimer of bilateral symmetry. The central E-region
contains the N-termini of all 6 chains. The D-region, which is connected with the Eregion by a coiled coil segment, is composed of the β- and γ-chain C-termini. The α-chain
C-termini fold back on the coiled coil and interact with the E-region. Fibrin formation
involves cleavage of FpA (fibrinopeptide, orange) by thrombin (fibron I), which
polymerizes into protofibrils. Subsequently, FpB (fibrinopeptide, green) is cleaved by
thrombin (fibrin II). FpB cleavage is associated with release of the C-terminal α-domains,
which interact for lateral aggregation (Undas et al., 2011).

Chitosan. Chitosan is also a linear polysaccharide that is composed of randomly
distributed β-(1-4) linked D-glucosamine (deacetylated unit) and N-acetyl-Dglucosamine (acetylated unit) (Figure 50). Chitosan can be made from chitin found in
crustacean shells. Crustacean shells are the second most abundant biopolymer, with
cellulose being the first (Assuncão-Silva et al., 2014). Since the origin of where chitosan
is derived can change, the physicochemical properties change and are directly related
from the source because of affect they have on the size and shape of the pores (Kim et al.,
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2014). Chitosan hydrogels can be created by different bonding of the molecules, and can
even form a hydrogel by itself through hydrogen bonds, hydrophobic interactions, and
chitosan crystallites (Assuncão-Silva et al., 2014; Kim et al., 2014). When looking at
chitosan by itself, without any additives, it shows neuroprotective effect and helps aid
physiological recovery in traumatic spinal cord injuries. Research shows when the
chitosan hydrogel loaded with neural stem cells was transplanted in complete spinal cord
transection and subacute spinal cord injury model of rats that there was an increase
survival rates and regeneration of the spinal cord. These results only showed functional
recovery when treated with growth factors and soluble Nogo-66 receptor in transection
model and dibutyryl cyclic-AMP in the subacute model. But in acute model of rats,
results showed enhancement of both functional recovery and nerve regeneration with
chitosan hydrogels loaded with bone marrow stromal cells (Kim et al., 2014).

(Lee et al., 2012)
Figure 50. Chemical structure of chitosan.
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Hyaluronic acid. Hyaluronic acidic is a natural polysaccharide consisting of
glucuronic acid and N-acetylglucosamine. Figure 51 below represents the chemical
structure. It is used as a hydrogel because of its ability to be completely biodegradable,
non-cytotoxic, and biocompatible, but it has weak mechanical properties and high
degradation rate. To increase the mechanical properties other polymers are incorporated
with the hyaluronic acid. Also, the surface of hyaluronic acid does not allow the cell to
bind in an efficient manner, but this problem is overcome by modifying the acid to allow
the cells to bind more easily. Researchers are trying to design the perfect hyaluronic acid
hydrogel with different modification, because it is known that hyaluronic acid can help to
reduce scar formation at the injury site. Some of the combinations that have been studied
are high molecular weight hyaluronic acid, one modified with nogo-66 receptor antibody,
and addition of brain derived neurotrophic factor (BDNF). The results showed that for the
high molecular weight and modified with nogo-66, it reduced astrocytes activation and
decreased chondroitin sulfate proteoglycans (CSPG) deposition in vivo. The hydrogel
containing brain derived neurotrophic factor prevented an inflammatory reaction and
increased motor functions in a rat spinal cord injury model (Kim et al., 2014).
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(National; CID=3084050)
Figure 51. Chemical Structure of Hyaluronic Acid.

Self-assembling peptides. Another different approach from hydrogels and cell
therapies in spinal cord injury research is the use of self-assembling peptides, which are
nanomaterials that have the capability to form a scaffold by themselves when present
within a solution that has similar properties to that of the extra cellular matrix (Kim et al.,
2014). Depending on the contents of the solution through the self-assembling peptides,
there can be changes to obtain a specific required response (Assuncão-Silva et al., 2014).
The self-assembling peptides are made up of short repeating units of amino acids that
produce nanofibrous scaffolds in response to thermal or pH. These peptides are used
because they are reabsorbable, allow biofunctionalizations, and can easily be made into a
liquid injectable that will form a scaffold when injected into the tissue. Studies have
shown that different self-assembling peptides have the ability to improve function and
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histological recovery in an acute rat model and promotes neurological recovery (Kim et
al., 2014).
Combinational Biomaterials
Combinational biomaterials are becoming the norm in spinal cord regeneration.
Biomaterials alone can help to improve injury, as mentioned in previous sections in this
chapter, with some limitations. These limitations as thought to be overcome by
combining biomaterials with cell based therapies. Some of these combinations were
mentioned briefly in the individual sections of both the cell based therapies and hydrogel
based therapies and, will be discussed in a bit more detail in this section.
The first combination that will be discussed is using neural stem cells (NSC) with
a poly-lactic-co-glycolic acid (PLGA). This scaffold was injected into spinal cord injury
rats and results showed cell viability for a greater length of time and improved functional
recovery of the rats according to Xiong et al., 2009 and Teng et al., 2002. Another study
conducted by Rauch et al., 2009, used a hemisection spinal cord injury model to deliver
both neural stem cells and endothelial cells. Researchers used two biomaterials
containing poly-lactic-co-glycolic acid as the outer section and poly (ethylene glycol) /
poly-L-lysine (PEG/PLL) as the inner section of this co-delivery system. The endothelial
cells were present within this scaffold to promote vascularization, which in theory helped
increase neural stem cells survival. Results of this study showed that there was an
increase in the blood vessels at the injury site, but the survival of the neural stem cells did
not increase.
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The next combination using MSCS with a biomaterial poly (D, L-lactide-coglycolide) / small intestinal submucosa (PLGA/SIS) in a complete transection spinal cord
injury showed that it started nerve regeneration. Most successful studies using MSCs use
macro porous hydrogels based on derivatives of with 2-hydroxyethly methacrylate
(HEMA), 2-hydroxypropyl methacrylamide (HPMA), or co-polymers of PHEMA. The
results of these studies are very promising with the hydrogel promoting cell growth, axon
growth in the proximal and distal stumps and reabsorption of the hydrogel by
macrophages within the body and its replacement with newly formed tissue. This tissue
was also found to contain connective tissue elements, blood vessels, astrocytic processes,
and neurofilaments (Assuncão-Silva et al., 2014).
The use of natural hydrogels to deliver mesenchymal stem cells have also been
studied, but not in as much detail as synthetic hydrogels. These studies include the use of
agarose, alginate, and fibrin among others. The results from these studies are not as
promising as the use of synthetic hydrogels, but are still being studied to improve the
results (Assuncão-Silva et al., 2014). Using combinational biomaterials for spinal cord
injuries holds much promise for the future, and future studies are needed to find cure for
SCI.
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Table 2
Therapeutic potential of combinational approaches based on cell therapy and
biomaterials for spinal cord injury treatment (Assuncão-Silva et al., 2014).
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Abstract
Changes in monosynaptic reflex, often used to study spasticity, has been tested
through the H-reflex in spinal cord injury (SCI) patients after rehabilitation training, such
as body weight support treadmill training or cycling. The combinational effects of
rehabilitation training and a bioengineered scaffold on spasticity in SCI animal model
have not been studied. We used a clinically relevant animal model of spinal cord
moderate contusion at T9/T10 with body weight support treadmill training and the
bioengineered scaffold poly (N-isopropylacrylamide-) poly (ethylene glycol)
(PNIPAAm-g-PEG) loaded with the growth factors BDNF/NT-3 to measure the
efficiency of the combinational bioengineered approach to treat spasticity. Five animal
groups were included in the study: sham, injury, SCI + body weight support treadmill
training (BWSTT), SCI + PNIPAAm-g-PEG with BDNF/NT-3 (Transplant), and SCI +
combination of body weight support treadmill training with PNIPAAm-g-PEG with
BDNF/NT-3 (combinational). Results indicate that there was an increase in the
overground BBB test scores from the BWSTT, and combinational groups from weeks 685

8, but not in the transplant only or injury groups when compared to the sham. There was
also a decrease in habituation of the H-reflex and restoration of rate depression properties
in both the BWSTT and combinational groups. This allows new pathways to be opened
to explore unique tissue-engineering approaches with promising clinical application for
patients with incomplete SCI’s.
Introduction
Spinal cord injury is a condition that affects about 40 million people worldwide
(Assuncão-Silva et al., 2014) with more than 11,000 new cases reported in the United
States and Canada alone (Lam et al., 2007). The number one leading cause of spinal cord
injuries are accidents while working (28%), followed by motor vehicle accidents (24%)
and sporting/recreation (16%). Spinal cord injuries are also the second leading cause of
paralysis (23%) (Christopher and Dana Reeve Foundation, April 2009). Due to the
disruption within the motor and sensory systems after SCI, paralysis, spasticity,
anesthesia, and hyper-reflexia below the lesion site is observed. Spasticity resulting from
SCI due to changes in the motorneuron properties is observed in 65-78% (Adams et al.,
2005) of SCI patents and is measured by the Hoffman or H-Reflex/monosynaptic reflex
(Reese et al., 2006). The H-reflex is elicited by the synaptic activation of motorneurons
by muscle afferents, following electrical stimulation of muscle nerves (Reese et al., 2006;
Skinner et al., 1996). In normal patients, the H-wave amplitude decreases with increasing
electrical stimulus (Reese et al., 2006), and after injury, becomes less sensitive which
produces a higher H/M ratio (Lee et al., 2005).
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Current treatments for spasticity after SCI include activity based rehabilitation
therapies, such as body weight support treadmill training (BWSTT). The overall goal of
this activity based rehabilitation therapy is to “target activation of the neuromuscular
system below the level of the lesion, with the goal of retaining the nervous system to
recover specific motor tasks” (Jones et al., 2012). This therapy focuses mainly on
incomplete injuries because there is some preservation of the pathways below the level of
injury, where as in a complete injury, there are no descending/spared pathways. Complete
spinal cord injuries have never shown any recovery in over-ground walking, whereas
body weight supported treadmill training has proven to enhance locomotor recover in
incomplete injury patients (Lam et al., 2007). Since it has been proven that body weight
supported treadmill training increased locomotor outcomes of incomplete spinal cord
injuries, it shows that the level of recovery depends on the amount of spared descending
pathways. To enhance the functional recovery while using this therapy, transplantation
treatment strategies are added. These transplantation strategies have to 1) minimize the
secondary injury 2) replace and minimize the survival of damaged cells and 3) alter the
local environment to be more conductive for regeneration (Jones et al., 2012). To
achieve the goals of transplantation strategies, neurotrophins growth factors, called
neurotrophins, are used. Neurotrophins, such as BDNF and NT3, are neuroprotective and
neuroregenerative agents that minimize tissue loss, promote regeneration and sprouting
of injured axons, and help bridge the gap of injury (Boyce et al., 2014). Clinical transition
of cell transplantation treatments secreting these neurotrophins still poses several
problems including rejection, and release of the cells and the approaches used (AssuncãoSilva et al., 2014). To overcome these problems, we propose using the bioengineered
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scaffold poly (N-isopropylacrylamide)-poly (ethylene glycol) (PNIPAAM-g-PEG) loaded
with neurotrophins. In past studies, PNIPAAm-g-PEG has shown to be highly
biocompatible, and biodegradable, and has the ability to release a drug over a long
duration of time. It can also be functionalized to secrete neurotrophins (Alexander et al.,
2014; Comolli et al., 2009). In summary, this study aims to investigate changes in H
reflex response in contused rats after combinational treatment strategy, using body weight
support treadmill training and PNIPAAm-g-PEG scaffold releasing BDNF/NT-3.
Methods and Materials
Spinal cord injury (contusion) and animal care. All animal protocols were in
accordance with NIH Guide for the Care and Use of Laboratory Animals and approved
by Rowan School of Osteopathic Medicine Institutional Animal Care and Use Committee
(IACUC). The study used a total of 38 adult female Sprague-Dawley rats (225-250 g,
Harlen, NJ). They were housed 2-3 per cage containing alpha-dry bedding with a
cardboard tube, on a 12-hour light-dark cycle, and had free access to food and water. The
38 rats were divided into 5 groups, as shown in Table 3. Groups 2-5 received SCI.
Animals in these groups were anesthetized with an intraperitoneally (i.p.) injection of
ketamine cocktail containing a mixture of ketamine (76 mg/kg, Fort Dodge Animal
Health, Fort Dodge, IA), xylazine (7.6 mg/kg, Ben Venue Laboratories, Bedford, OH),
and acepromazine maleate (0.6 mg/kg, Boehringer Ingelheim Vetmedica, Inc, St. Joseph,
MO). Animals were shaved and then cleaned with alcohol and betadine, before T9/T10
laminectomy was performed to expose the dura. They received a moderate contusion
injury from an impact device with a 10 gram, 2.0 mm diameter rod that dropped from 25
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mm on exposed spinal cord. Subcutaneous fat was placed on the exposed dura preventing
adhesions and 4.0 sutures closed the back muscles. The wound was closed with surgical
wound clips. Rats were placed on a heating pad until conscious and moving regularly.
Water bottles in the cages were replaced with long stems, and H2O hydrogels and food
were placed in the cage in the event that the rats could not reach food/water. After
surgery, rats were injected subcutaneously with saline (3-5 ml) two times a day and
Ampicillin (.3 cc, 22.7 mg/ml s.c., b.i.d.) once a day. Saline injections were given 10-12
hours apart, along with manually expressing the rat’s bladder three times a day for 2
weeks after date of surgery. This minimized dehydration and urinary tract infection. Rats
with signs of illness after 2 weeks post-surgery were given Children’s Tylenol (.4 ml, 100
mg/kg) orally one time a day for 2 weeks or as needed.

Table 3
Number of animals in each group.
Group Number

Injury/Training Received

Number of Animals

Group 1

Sham

N=6

Group 2

Contused

N=8

Group 3

Contused + BWSTT

N=8

Group 4

Contused + Scaffold +
Neurotrophins

N=8

Group 5

Contused + Scaffold +
Neurotrophins + BWSTT

N=8
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Transplantation. One-week post spinal cord injury Groups 4 and 5 received
scaffold and neurotrophin transplants. Rats were anesthetized with the ketamine cocktail
and prepared for surgery similar to the initial contusion surgery. The location of injury
was identified and re-exposed, and approximately 5 ml of PNIPAAm-g-PEG loaded with
BDNF (0.5 x 106 /5 µl) and NT-3 (0.5 x 106 /5 µl) was injected with a positive
displacement pipette at the injury site. Post-operative care stayed the same as with the
initial contusion injury, 2 weeks of saline, Ampicillin, and bladder expression.
Behavioral analysis. All rats were tested using the Basso, Beattie and Bresnahan
(BBB, Basso et al., 1995) scale to measure their hindlimb function in an open field
locomotion. Rats were video recorded for 4 minutes each in a circular enclosure and then
scored based on their neurological rating scale, ranging from 0 (complete hindlimb
paralysis) to 21 (normal hindlimb locomotion). The BBB test was conducted before the
spinal cord injury (baseline), 2-3 days after surgery, and then each week thereafter until
week 10 by a trained observer and scored by another blind observer.
Treadmill training. Figure 52 shows a custom-built treadmill with a load cell
developed for this study. The load cell was attached to the body weight support (BWS)
rod and read the actual load that the rat exerted on the rod during locomotion. Individual
components of the custom treadmill are labeled and explained in Figure 53. Rats were
secured to the BWS arm via a soft cloth vest and attached using Velcro strips and trained
at 75% BWS at 7 cm/sec. This was done for rats in Groups 3 and 5 one-week post-injury
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or transplant. Rats were trained 5 days a week, 1000 steps/day for up to 8 weeks as
shown in Figure 5.3.

Figure 52. Custom treadmill and body weight support (BWS).
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Figure 53. Custom body weight support (BWS) treadmill with components labeled. A)
National Instruments myDAQ: paired with LabVIEW VI, the myDAQ issues commands
to the motor controllers (B and C) and interprets the signal from the load cell amplifier
(F), B) Treadmill Motor Controller: controls stepper motor used to drive the treadmill, C)
Spring Tensioning Motor Controller: controls the stepper motor used to tension the
spring, D) Power Supply: Supplies power to the motors, E) Treadmill Stepper Motor, F)
Course Adjustment Knob: adjusts the height of the body weight support carriage, G)
Animal Attachment Plate, H) Load Cell: measures the weight the animal is feeling after
the spring provides assistance, I) Load Cell Amplification Circuit: amplifies the load cell
signal before being processed by the my DAQ, J) Tension Spring: provides assistance to
the animal when weight is supported, K) Spring Tensioning Motor: stepper motor that
changes the tension of the assistance spring, L) Treadmill Belt, M) Treadmill Base, N)
Body Weight Support Carriage: carriage attached to the course adjustment which moves
the spring tensioning system, load cell, and variable angle specimen attachment.

Figure 54. Rat undergoing BWSTT.
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Electrophysiology (H-reflex). Eight weeks after contusion or transplant, rats were
anesthetized with ketamine cocktail, and their right hindlimbs were shaved, and then
cleaned with alcohol. The right tibial nerve was exposed and lifted using a hook electrode
(Figure 55), with active needle electrodes inserted between the fourth and fifth
metatarsal, and the reference/recording electrode inserted in the skin of the fifth digit.
The nerve was preserved using mineral oil throughout the test. The tibial nerve was
stimulated using an A-M Systems Isolated Pulse Stimulator Model 2100 where the
response was amplified with an A-M Systems Differential Amplifier Model 1700. The
signal was sent to a Tektronix TDS 310 two channel oscilloscope and National
Instruments USB-6212 BNC, which sent the information to the LabVIEW program
loaded on the computer as shown in Figure 56. First the nerve was stimulated at .3 Hz to
determine the threshold and maximum stimulus response levels. Once the threshold was
found, the H-reflex of the tibial nerve was conducted at .3 Hz and 10 Hz at the particular
stimulus. A 5-10-minute delay was introduced between the two tests to allow the nerve to
return to baseline electrophysiological state.

Figure 55. Bipolar hook electrode.
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A

B

C

D

Figure 56. Set up of A-M Systems Isolated Pulse Stimulator Model 2100, A-M Systems
Differential Amplifier Model 1700, and Tektronix TDS 310 oscilloscope used for Hreflex. A) Mineral oil, B) Stimulator, C) Amplifier, D) Oscilloscope.
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Figure 57. NI USB-6212 used to collect M and H waves.

Figure 58. A schematic diagram of how the M and H waves are stimulated and the path it
travels to the spinal cord to produce the response.

Statistical analysis. Statistical analysis was done using repeated measure
ANOVA for BBB data between groups and time, with time taken as a repeated measure
beginning at 1 week after training. The Turkey’s test was used for post hoc analysis of
parametric data, and the Mann-Whitney U test for nonparametric data. H-reflex was
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analyzed using a one-way ANOVA between groups, followed by Turkey’s post hoc test
when appropriate. All values are expressed as mean +/- standard error of mean (SEM).
All statistical analyses were performed using SPSS 11.5 for Windows Software, and
significance was determined using a p-value of <0.05.
Results
Behavior test-overground BBB test. A baseline and weekly BBB scores are
shown in Figure 59. Functional recovery was observed in BWSTT and combinational
groups (Groups 3 and 5) but were not statically different from the Sham, Injury, and
Transplant groups (Groups 1,2 and 4) (Figure 59).
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Figure 59. BBB Scores.

H-reflex. Figure 60 shows H-reflex response waveforms to stimulation at 0.3 and
10 Hz for all five groups. Figure 60A represents recording from a control animal
stimulated at 0.3 Hz (the 100% response), along with (Figure 60B) the response at 10 Hz
(group mean ± SEM, 15.3±3.9% of the response at 0.3 Hz), and the response from an
injury animal at 0.3 Hz (Figure 60C) (100%) and at 10 Hz (65.7±5.7%) (Figure 60D).
Figure 60E and 60F show the H-reflex response of a transplant animal at 0.3 Hz (100%)
and 10 Hz (58.7±8.8%). Figures 60G and 60H show the H-reflex response of a BWSTT
animal at 0.3 Hz (100%) and 10 Hz (26.7±6.9%). Figures 60I and 60J show the H-reflex
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response of a combinational animal at 0.3 Hz (100%) and 10 Hz (26.7±6.9%). These
recordings demonstrate that in control animals, there is frequency-dependent depression,
and this depression is lost in the injury and transplant groups, but not in the BWSTT and
combinational groups.
Averages of the last 11 M and H responses were calculated for both stimulus
frequency trains. Figure 61 shows the H/M ratio for each group at 10 Hz. This H/M ratio
was plotted to determine the H-reflex rate depression seen in each group. Frequency
dependent depression was observed to be restored in the BWSTT and combinational
groups and not in the injury and transplant groups. Injury and transplant groups (*) were
significantly different from control, BWSTT, and combinational groups (+) at the p<0.05
level. These results suggest that BWSTT and combinational treatment leads to a
restoration of frequency dependent depression of the H-reflex. ANOVA of these groups
showed statistically significant differences between experimental groups (df=4,
F=49.854, P<0.05). Post hoc comparison between all groups showed significance at 10
Hz between the control, BWSTT, and combinational groups and the injury and transplant
groups.
Figure 62 is a graph of the habituation of the H-reflex following stimulation at 0.3
and 10 Hz for the following groups of animals: Sham, Injury, Transplant, BWSTT, and
Combinational. Statistically significant differences between injury and transplant (*)
groups and the control, BWSTT, and combinational (+) groups were seen at the p<0.05
level for 10Hz. ANOVA of these groups showed statistically significant difference
between experiment groups (df=4, F=14.212, p<0.05). Post hoc comparison also showed
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the same significance at 10 Hz as the H/M ratio plot. The control, BWSTT, and
combinational groups were significantly different from the injury and transplant groups.
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Figure 60. Averages of H-reflex recording at 0.3 and 10 Hz. The M-wave amplitude
remains constant while the H-wave amplitude decreases with increasing stimulus
frequency. A) H-reflex waveform response to stimulation at 0.3 Hz on a control rat. B)
H-reflex waveform response to stimulation at 10 Hz in the same control rat. C) H-reflex
waveform response to stimulation at 0.3 Hz in an injury only rate. D) H-reflex waveform
response to stimulation at 10 Hz in the same injury only rat. There is a decrease in the
frequency-dependent depression compared to control. E) H-reflex waveform response to
stimulation at 0.3 Hz in transplant (scaffold and neurotrophins) animal. F) H-reflex
waveform response to stimulation at 10 Hz in the same transplant rat. The transplant
group also has a decrease in the frequency-dependent depression compared to control. G)
H-reflex waveform response to stimulation at 0.3 Hz in a body weight support treadmill
training (BWSTT) rat. H) H-reflex waveform response to stimulation at 10 Hz in the
same BWSTT rat. I) H-reflex response waveform response to stimulation at 0.3 Hz in a
combinational rat. J) H-reflex response waveform response to stimulation at 10 Hz in the
same combinational rat. Note that the BWSTT and combinational groups had a return of
frequency-dependent depression of the H-reflex. Calibration bars vertical 2 mV,
horizontal 0.02 sec.
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Figure 61. H ratio – 10/0.3 Hz for each group. The injury and transplant groups (*) are
significantly different from the sham, BWSTT, and combinational groups (+) at the
P<0.05 level. *, +: Non-Significant.
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Figure 62. H/M Ratios at 0.3 and 10 Hz for control (circles), injury (square), BWSTT
(diamond), transplant (asterisk) and combinational (triangle). Data normalized at 0.3 Hz
indicates the injury and transplant groups (*) to be significantly different from the
BWSTT, sham, and combinational groups, P<0.05 level (+). *, +: Non-Significant.

Discussion
The hypothesis for this study is that neurotrophins secreting scaffold will (1) protect
and minimize the secondary damage that the descending pathways undergo (2) promote
growth of new pathways and (3) help achieve a better H-reflex response after body
weight support treadmill training (BWSTT). Part 1 and 2 of the hypothesis will be proven
later in phase 2: histology, part 3 was proven to be true according to results of part 1
presented in this paper.
The behavior analysis (BBB) showed no significance difference between groups. This
is a course measurement of behavior recovery, that does not look at capturing
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improvement in weight support and locomotion speed. This is why he second part of the
study is kinematics analysis which is still ongoing. Kinematic analysis was tested at 75%,
65%, and 55% body weight support at a speed of 7cm/s and 10cm/s and this will help
show if there is functional recovery within BWSTT and combinational groups.
Another thing to point out is why was there improvement of the H-reflex but not in
the BBB scores (motor function). In motor functions, there are both poly and mono
synaptic pathways that are involved, whereas the H-reflex is just a monosynaptic
pathway (Lee et al., 2005; Gozariu et al., 1998). The monosynaptic pathways still give us
critical information regarding spasticity which we know as a secondary complication
after SCI (Adams et al., 2005).
The H-reflex has been a reliable and accurate measure of the changed spinal circuitry
after spinal cord injury (SCI) in both contusion/compression (Lee et al., 2005; Magnuson
et al., 1999; Skinner et al., 1996) and transection (Reese et al., 2006; Yates et al., 2008)
models as well as in humans (Boorman et al., 1992; Phadke et al., 2006; Phadke et al.,
2007; Rayegani et al., 2011; Schindler-Ivens et al., 2000; Yates et al., 2008). The
contusion/compression models closely resemble the most common human spinal cord
injuries (Blight et al., 2000; Magnuson et al., 1999), and can be used to assess all stages
of the injury (spinal cord trauma, secondary tissue destruction, tissue repair process,
stabilization of chronic lesion, and long-term disability) (Blight et al., 2000). The
transection model is mainly used to test nerve fiber regeneration and cell transplantation
(Blight, 2000). In the contusion/compression models, it is possible for the animals to
regain some motor function, which is commonly observed in humans after SCI (Eaton,
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2003). Our study used a moderate contusion injury, because we aimed to study the effects
of bioengineering scaffold releasing neurotrophins and body weight supported treadmill
training on H-reflex after incomplete injuries.
After SCI, the spinal circuitry changes and there is a reorganization (Reese et al.,
2006) because of the loss of descending fibers modulating inhibitory fibers. These
descending fibers are responsible for presynaptic inhibition of IA afferents onto
motoneurons (Skinner et al., 1996). The H-reflex amplitude has shown to be proportional
to the number of motoneurons that are activated at any stimulus, and the reflex measures
the transmission between muscle afferents and the motorneurons (Skinner et al., 1996)
and is influenced by the supraspinal control (Lee et al., 2005). After injury, the H-reflex
response is exaggerated greatly (Phadke et al., 2007). The change in H-reflex amplitude
at different stimulus frequency is the change in the excitability of the reflex pathways
(Schindler-Ivens et al., 2000). At a higher frequency in a normal animal, a frequencydependent depression is seen in the H-reflex, and after SCI, there is a decrease in the
depression (Figure 60). This frequency-dependent depression results from the
presynaptic inhibition due to lost descending fibers and the lack of changes in the
motorneuronal excitability, which essentially controls the amplitude of the H-reflex
(Skinner et al., 1996). Reese et al., 2006 reported that the decreased depression at low
frequencies is related to a decrease in presynaptic inhibition. This draws our first
hypothesis that by protecting and minimizing secondary damage of the descending
pathways, a restoration of the H-reflex can occur.
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It has been previously studied that the H-reflex is altered with rhythmic motions such
as stepping, walking, running, and pedaling (Reese et al., 2006). Many studies have
looked at incorporating an exercise regimen to produce a more normalized H-reflex
depression because the exercise can compensate for the loss in presynaptic inhibition that
happens after SCI, because the hindlimb/leg muscles are being alternately stretched in
some form (Phadke et al., 2007; Skinner et al., 1996). Our study used a training regimen
of BWSTT and the results showed that the BWSTT and combinational (Tx and BWSTT)
groups did present a more normalized frequency rate depression as in the control group,
when compared to the injury and transplant groups. These results were also reported by
Skinner et al., 1996, where exercise helped to reorganize and preserve presynaptic
inhibition producing an H-reflex amplitude with normal levels of frequency-dependent
depression. In a similar study conducted by Reese et al., 2006, motorized bicycle exercise
training (MBET) was shown to restore frequency-dependent depression of the H-reflex to
normal level in the exercise, transected group. Boorman et al., 1992 study showed that Hreflex changes observed during pedaling and walking were due to presynaptic inhibition.
It is also important to note that the level at which the spinal cord is transected can affect
the H-reflex results at high frequencies. Skinner et al., 1996 supports the theory that at the
T10 thoracic level, there is a reduced depression of the H-reflex at high frequencies. A
study conducted by Reese et al., 2006 reported differently, in that their T10 transected
group did not show any frequency-dependent depression at most stimulation frequencies.
There have also been studies that have looked at how the severity effects the H-reflex.
One particular study by Lee et al., 2005 showed that the changes that were observed in
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the H-reflex results may be related to the severity of SCI. Our study used a moderate
contusion injury across all of the groups.
Another aspect of SCI that becomes a problem to patients is spasticity. Spasticity can
be seen in many forms such as hyperreflexia, clonus, clasp-knife responses, long-lasting
cutaneous reflexes, and muscle spasms (Elbasiouny et al., 2010). One most commonly
studied component of spasticity is hyperreflexia. The exact reason why hyperreflexia
occurs is still unknown, but there have been reports of loss/decrease of presynaptic
inhibition of Ia terminals, increase in postsynaptic receptor excitability, synapse growth
and changes in intrinsic properties of alpha motorneurons (Reese et al., 2006; Yates et al.,
2008) are involved. In humans, spasticity has been related to specific changes in
excitability patterns of the soleus H-reflex (Phadke et al., 2007). Studies have shown that
hyperreflexia is evident in animal models of SCI (Skinner et al., 1996), but does not
happen immediately after SCI (Schindler-Ivens et al., 2000). It develops within 6-28 days
after SCI in a contusion animal model (Yates et al., 2008) and has been shown to be
evident even after 30 days (Reese et al., 2006). Since the hyperreflexia can be due to the
loss/decrease of presynaptic inhibitions, researchers incorporate an exercise regimen that
is known to compensate for the loss of presynaptic inhibitions and potentially decrease
hyperreflexia. In our study, the H/M ratio was plotted for each group to see the
habituation of the H-reflex. The lack of habituation shows that hyperreflexia may be
present within those groups. The results showed that the injury and transplant groups
presented very little habituation and the control, BWSTT, and combinational groups
showed habituation. These results show that there was a possible increase in presynaptic
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inhibition in the BWSTT and combinational groups producing a more normalized Hreflex response.
The combinational group used in our study has a combination of BWSTT and the
bioengineered scaffold PNIPAAm-PEG loaded with neurotrophins (BDNF/NT-3).
Biomaterials scaffolds, in general, are used to help bridge the gap between the lost tissue.
They provide a site for an implant or host cells, and are capable of releasing therapeutic
agents within the injured spinal cord, such as neurotrophins. These scaffolds also have
the capability to preserve the local environment of the spinal cord through decreasing
apoptosis of cells, inflammation and scar formation. The biomaterials are constructed
from synthetic polymers that are easily blended together to create a unique biomaterial
with the mechanical and physiochemical properties needed for its application (Kim et al.,
2014). Some of PNIPAAm unique properties, which make it suitable for implantation
within the spinal cord, are that is has compression modulus values in the range from 0.7
to 600 kPa and the self-ability to show thermal transitioning (Alexander et al., 2014).
PEG also has a unique property that allows it to have an immune protecting effect on the
spinal cord defects, because it helps to reseal cell membranes, which limits apoptosis
(Assuncão-Silva et al., 2014; Kim et al., 2014). Also, when implanted into the spinal
cord, the PEG polymer is very resistant to recognition by the immune system not
producing a response from the body (Assuncão-Silva et al., 2014). This unique
combination of PNIPAAm-PEG has been previously studied in spinal cords for cell
transplantation, such as bioactive neurotrophins (Comolli et al., 2009; Grous et al., 2013;
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Piantino et al., 2006) and load-bearing soft tissue applications (Alexander et al., 2014;
Thomas et al., 2010).
These reported studies all used some form of the hydrogel PNIPAAm-PEG,
except for Piantino et al., 2006. Piantino et al., 2006 looked at how PEG alone, coupled
with NT-3, would improve recovery in a T8 laminectomy. The study reported improved
locomotor recovery and greater axon growth when compared to control. Another study
conducted by Grous et al., 2013 performed a cervical dorsolateral funiculotomy, and
results showed that the cross-linked hydrogel PNIPAAm-g-PEG allowed axonal growth
and successfully delivered BDNF into the injured spinal cord, while increasing recovery
rate of fine motor function, when compared to control group (PNIPAAM-g-PEG only).
Comolli et al., 2009 performed a similar study to Grous et al., 2013, but looked further
into the neurotrophins and material properties of the neuronal tissue. The results showed
that using PNIPAAM-PEG, loaded with NT-3 and BDNF neurotrophins were sustained
for up to 4 weeks within the injury site, and bioactivity was confirmed after 4 weeks.
Overall results from this study showed that PNIPAAm-PEG scaffold can be modified to
match the mechanical properties of the neuronal tissue present within the spinal cord.
Previous studies like Comolli et al., 2009 showed that PNIPAA-PEG it is capable of
releasing a drug over a long period of time and is biocompatible and biodegradable.
The growth factors NT-3 and BDNF are neurotrophins found in peripheral nerves
and the spinal cord. They have shown to affect circuit behavior within the spinal cord.
Long term treatment with these neurotrophins can provide a detour around the injury site
of the spinal cord in neonatal and adult rats. Specifically looking at NT-3, it helps in the
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survival of sensory afferent and it strengthens the group Ia synaptic projection to
motorneurons. BDNF does not have an effect of the strength of the synaptic projections
like NT-3, but it enhanced motor neuron excitability, which will produce a better Hreflex amplitude. It can also reduce synaptic inhibition (Boyce et al., 2014).
Conclusion
This study strengthens the results of previous studies in finding that an exercise
regimen can help restore the frequency-dependent depression of the H-reflex (Lee et al.,
2005; Reese et al., 2006; Skinner et al., 1996; Yates et al., 2008). Our study showed this
restoration was present in the BWSTT and combinational groups, but not in the transplant
group. The same effect was seen with the BBB test, such that the BWSTT and
combinational groups exhibited functional recovery, but not the transplant group when
compared to sham. There was also a decrease in habituation of the H-reflex, seen in both
the BWSTT and combinational groups. These results open a new gateway for incomplete
SCI patients through a unique tissue-engineering approach that has shown promise in
clinical application. Our unique tissue engineering approach of using PNIPAA-m-PEG
loaded with BDNF/NT-3 improved the H-reflex response in all aspects from habituation,
spasticity, and frequency-dependent depression, but not as well as the BWSTT group.
Future studies can combine this PNIPAA-m-PEG scaffold with other growth promoting
agents, as well as different exercise regiments to explore the beneficial effects of the
proposed combination treatment strategy in incomplete SCI animal models to see if a
unique combination is proven more beneficial than BWSTT alone. This unique tissue-
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engineering approach did not show a better result when compared to the BWSTT group,
but did show promise when compared to sham and injury group.
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Chapter 6
Future Work
There is much more future work that has to be done in order to cure spinal cord injuries.
The study posed some limitations with respect to the bioengineered scaffold and
rehabilitation techniques. Future work is needed to improve the study and the outcomes.
Future studies should first look at the PNIPAAm-g-PEG with neurotrophins scaffold to
access the changes in the anatomical and synaptic plasticity. These changes will access
the neuroprotective and neroregenerative properties and to see if the scaffold was
successful in establishing anatomical connections, while preserving spared descending
pathways. If the PNIPAAm-g-PEG scaffold was found to be successful, then more
studies should be conducted with that scaffold to improve the procedure and outcome of
the studies. The scaffold injection process should be tested to access the amount of
scaffold that was actually injected into the injury site. Problems arise with the scaffold
leaking during injection. There needs to be a set procedure that can quantify and ensure
the same amount of scaffold is injected into the injury site each time. Taking this into
consideration can allow for better results and will eliminate the outliers that may have
received more or less of the scaffold.
Future studies should also look at using different exercise regiments, such as
robotic treadmill training because it is more accurate and precise during training (Querry
et al., 2008). In our study this can be the reason why the BWSTT and combinational
groups showed no difference statically. Another exercise regimen that can be tested with
our bioengineered scaffold is motorized bicycle exercise. Skinner et al., 1996 and Reese
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et al., 2006 studies showed that it was capable of restoring the H-reflex, so I would test
for difference in the training and combinational groups because we did not see it in our
study.
Studies should also look at different bioengineered scaffolds that have already
proven helpful in some form for spinal cord injury repair. They should be tested to access
their neuroprotective and neuroregeneration properties. Once these scaffolds are
identified to have neuroprotective and neuroregeneration properties, they should be tested
with different growth factors. Our transplant group using PNIPAAm-PEG loaded with
BDNF/NT-3 did not show restoration of the H-reflex so a future study can look at
replacing BDNF with NGF. NGF is known to prevent degeneration of neurons (Nerve)
instead of encouraging neurogenesis (birth of neurons) like BDNF does (Patrick et al.,
2011). Also combining NGF with NT-3 will allow different population to be affected by
the neurotrophins (Nerve).
Another direction that future work can take is to study combinational
biomaterials. These combinational biomaterials combine both cell-based therapies with
hydrogel-based biomaterials. Since each part separately has shown to have some form of
neuroprotective and neuroregenerative properties, they can be combined in a unique way
to enhance these properties and to provide repair for spinal cord injury. There are many
combinations that are able to be tested, but some may pose more ethical issues than
others. This is the balance that researchers and society have to work with, but once there
is a balance, combinational biomaterials have the best chance in spinal cord injury repair.
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Appendix
Definitions
Adipocyte – Fat cell
Afferent – Bearing or conducting inward; specifically: conveying impulses toward the
central nervous system
Aliphatic – Of, relating to, or being an organic compound (as an alkane or alkene)
having an open-chain structure
Angiogenesis – The formation and differentiation of blood vessels
Anterior – Relating to or situated near or toward the head or toward the part in headless
animals most nearly corresponding to the head; situated toward the front of the
body
Antidromic – Proceeding or conducting in a direction opposite to the usual one – used
especially of a nerve impulse or fiber
Apoptosis – A genetically directed process of cell self-destruction that is marked by the
fragmentation of nuclear DNA and is a normal physiological process eliminating
DNA-damages, superfluous, or unwanted cells – called also programmed cell
death
Arachnoid – A thin membrane of the brains and spinal cord that lies between the dura
mater and the pia mater
Astrocytes – A star shaped cell; especially: and comparatively large much-branched
neuroglial cell
Axon – A usually long and single nerve-cell process that usually conducts impulses away
from the cell body
Bioengineered - The application of biological techniques (as genetic recombination) to
create modified versions of organisms
Blood-Brain Barrier – A barrier created by the modification of brain capillaries (as by
reduction in fenestration and formation of tight cell-to-cell contacts) that prevents
many substances from leaving the blood and crossing the capillary walls into the
brain tissue
Cardiac Output – The volume of blood ejected from the left side of the heart in one
minute
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Cerebrospinal Fluid - A liquid that is comparable to serum but contains less dissolved
material, that is secreted from the blood into the lateral ventricles of the brain, and
that serves chiefly to maintain uniform pressure within the brain and spinal cord
Chondrocyte – A cartilage cell
Clonus – A series of alternating contractions and partial relaxations of a muscle that in
some nervous diseases occurs in the form of convulsive spasms
Dendrite – Any of the usually branching protoplasmic process that conducts impulses
toward the body of a nerve cell
Distal – Situated away from the part of attachment or origin or a central point as a:
located away from the center of the body b: located away from the mesial plane of
the body
Dorsal – Being or located near, on, or toward the upper surface of an animal (as a
quadruped) opposite the lower or ventral surface; being or located near, on, or
toward the back or posterior part of the human body
Dura Mater – The tough fibrous membrane lines with endothelium on the inner surface
that envelopes that brain and spinal cord external to the arachnoid and pia mater
that in the spinal cord is separated from the bone by a considerable space and
contains no venous sinuses
Efferent – Conducting outward from a part or organ specifically: conveying nervous
impulses to an effector
Endoneurial – Endonerurium – The delicate connective tissue network holding
together the individual fibers of a nerve
Endoneurium – The delicate connective tissue network holding together the individual
fibers of nerve trunk
Epineurium – The external connective tissue sheath of a nerve trunk
Extension – The stretching of a fractured or dislocated limb so as to restore it to its
natural position: an unbending movement around a joint in a limb (as the knee or
elbow) that increases the angle between the bones of the limb at the joint
Extracellular – Situated or occurring outside a cell or the cells of the body
Fibrocartilage – Cartilage in which the matrix, except immediately about the cells, is
largely composed of fibers like those of ordinary connective tissue; also: a
structure or part composed of such cartilage
Flexion – A bending movement around a joint in a limb (as the knee or elbow) that
decreases the angle between the bones of the limb at the joint
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Glial – Glia – Supporting tissue that intermingles with the essential elements of nervous
tissue especially in the brain, spinal cord, and ganglia and is composed of a
network of fine fibrils and of flattened stellate cells with numerous radiating
fibrillary processes
Habituation – A form of non-associative learning characterized by a decrease in
responsiveness upon repeated exposure to a stimulus
Hemorrhaging – A copious discharge of blood from the blood vessels
Hydrogel – A gel in which the liquid is water
Hydrophilic – of, relating to, or having a strong affinity for water
Hyper-excitability – The state or condition of being unusually or excessively excitable
Hyperextension – To extend so that the angle between bones of a joint is greater than
normal; also: to extend (as a body part) beyond the normal range of motion
Hyperreflexia – Over activity of physiological reflexes
Inflammation – A local response to cellular injury that is marked by capillary dilatation,
leukocyte infiltration, redness, heat, pain, swelling, and often loss of function and
that serves as a mechanism initiating the elimination of noxious agents of
damaged tissue
Intramedullary – Situated or occurring within a medulla; especially: involving use of
the marrow space of a bone support
Kyphosis - Exaggerated backward curvature of the thoracic region of the spinal column
Laminae – A thin plate or layer especially of an anatomical part
Laminectomy – Surgical removal of the posterior arch of a vertebra
Lateral – Of or relating to the side; especially, of a body part: lying at or extending
toward the right or left side: lying away from the median axis of the body
Leukocyte – White blood cell, a cell (as a macrophage) of the tissues comparable to or
derived from a leukocyte
Lordosis – Exaggerated forward curvature of the lumbar and cervical regions of the
spinal column
Lymphocyte – Any of the colorless weakly motile cells originating from stem cells and
differentiating in lymphoid tissue (as of the thymus or bone marrow) that are the
typical cellular elements of lymph, include the cellular mediators of immunity,
and constitute 20 to 30 percent of the white blood cells of normal human blood
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Macrophage – A phagocytic tissue cell of the immune system that may be fixed or freely
motile, is derived from a monocyte, functions in the destruction of foreign
antigens, and serves as an antigen-presenting cell
Matrix – The extracellular substance in which tissue cells (as of connective tissue) are
embedded
Medial Malleolus – A strong pyramid shaped process of the tibia that projects distally on
the medial side of its lower extremity at the ankle
Median – Situated in the middle; specifically: lying in a plane dividing a bilateral animal
into right and left halves
Metatarsal – Of, relating to, or being the part of the human foot or of the hind foot in
quadrupeds between the tarsus and the phalanges that in humans comprises five
elongated bones, which form the front of the instep and ball of the foot
Mixed Nerve – A nerve containing both sensory and motor fibers
Monocyte – A large white blood cell with finely granulated chromatin dispersed
throughout the nucleus that is formed in the bone marrow, enters the blood, and
migrates into the connective tissue where it is differentiated into a macrophage
Monomer – A chemical compound that can undergo polymerization
Monosynaptic – Having or involving a single neural synapse
Motor – Of or relating to, or being a motor neuron or a nerve containing motor neurons;
of, relating to, concerned with, or involving muscular movement
Multipolar – Having several dendrites
Myelinated – Having a myelin sheath
Myelination – The process of acquiring a myelin sheath; the condition of being
myelinated
Nerve Fiber – Any of the processes (as an axon or a dendrite) of a neuron
Neuroglia – glia: Supporting tissue that is intermingled with the essential elements of
nervous tissue, especially in the brain, spinal cord, and ganglia and is composed
of a network of fine fibrils and of flattened stellate cells with numerous radiating
fibrillar processes
Neurolemma – Neurilemma : The outer layer surrounding a Schwann cell of a
myelinated axon
Neuron – One of the cells that constitute nervous tissue, that have the property of
transmitting and receiving nervous impulses, and that possess cytoplasmic
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processes which are highly differentiated frequently as multiple dendrites or
usually as solitary axons, and which conduct impulses toward and away from the
cell body
Neuroprotective - Serving to protect neurons from injury or degeneration
Neurotransmitter – A substance that transmits nerve impulses across a synapse
Neurotrophin – Neurotrophic factor: Any of a group of neuropeptides (as nerve growth
factor) that regulate the growth, differentiation, and survival of certain neurons in
the peripheral and central nervous system
Neutrophil – A granulocyte that is the chief phagocyte white blood cell
Olfactory Bulb – A bulbous anterior projection of the olfactory lobe that is the place of
termination of the olfactory nerves
Olfactory Nerve – Either of the pair of nerves that are the first cranial nerves, that serve
to conduct sensory stimuli from the olfactory organ to the brain, and that arise
from the olfactory cells and terminate in the olfactory bulb
Oligodendrocyte – A glial cell resembling an astrocyte, but smaller with few and slender
processes having few branches and forming the myelin sheath around axons in the
central nervous system
Orthodromic – Proceeding or conducting in a normal direction – used especially of a
nerve impulse or fiber
Osteoblast – Bone forming cell
Paralysis – Complete or partial loss of function especially when involving the power of
motion or of sensation in any part of the body
Perineurium –The sheath of connective tissue that surrounds a bundle of nerve fibers
Phagocyte – A cell (as a macrophage or neutrophil) that engulfs and consumes foreign
material (as microorganisms) and debris (as dead tissue cell)
Pia Mater – The delicate and highly vascular membrane of connective tissue investing
the brain and spinal cord, lying internal at the arachnoid and dura mater, dipping
down between the convolutions of the brain, and sending an ingrowth into the
anterior fissure of the spinal cord
Pluripotent – Not foxes as to developmental potentialities; especially: capable of
differentiating into one of many cell types
Polymer – A chemical compound or mixture of compounds formed by polymerization
and consisting essentially of repeating units
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Posterior –Situated behind: as a: situated at or toward the hind part of the body: caudal b:
dorsal – used of human anatomy in which the upright posture makes dorsal and
caudal identical
Process – A part of the mass of an organism or organic structure that projects outward
from the main mass
Soleus – A broad, flat muscle of the calf of the leg that lies deep to the gastrocnemius,
arises from the back and upper part of the tibia and fibula and from a tendinous
arch between them, inserts by a tendon that unites with that of the gastrocnemius
to form the Achilles tendon, and acts to reflex the foot
Stroke Volume – The volume of blood pumped from a ventricle of the heart in one beat
Synapse – The place at which a nervous impulse passes from one neuron to another
Tibial Nerve – The large nerve in the back of the leg that is a continuation of the sciatic
nerve and terminates at the medial malleolus in the lateral and medial plantar
nerves
Pease, R. W. (2006). Merriam-Webster's medical dictionary. Springfield, MA: MerriamWebster.
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